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ABSTRACT 
 
The latest evidence indicates that 50,000 Canadians will experience a stroke in 2013.  The 
hospital care, rehabilitation, and long term care associated with a stroke places a significant 
burden on our health care system.  Lost productivity and premature death have an immeasurable 
impact on communities in our province as well as the rest of the country.  Small, less populated 
regions such as Saskatchewan may be underrepresented in national data utilized in the 
development of national prevention and treatment strategies across the country.  The absence of 
local research has necessitated the use of national information to guide prevention, treatment 
education and programming in Saskatchewan. 
The goals of this study was to provide a descriptive profile of stroke and transient ischemic 
attack cases admitted to Royal University Hospital over the period of April 1, 2009 to March 
31
st
, 2010 and to assess the acute management of these cases as defined in the Canadian Best 
 
Practice Recommendations for Stroke Care (Strategy, 2010).  A randomized sample of 200 cases 
 
55 years and older was selected for a retrospective descriptive study involving review of adult 
stroke case records.  Personal demographics and healthcare performance through the use of 
measures provided in The Canadian Best Practice Recommendations for Stroke Care (Canadian 
Stroke Network (CSN) and Heart and Stroke Foundation of Canada (HSFC), 2010) were 
evaluated. 
The results indicated many similarities to available national information on type of stroke, risk 
factors, gender, and age.  Hospital adherence to national guidelines comparing selected 
indicators was exceeded in some areas, and met in most.  The remaining indicators provide an 
opportunity for improvement and possibly more research. 
 This regional information supplements the available Canadian information and could be used to 
guide planning and care strategically targeting Saskatchewan  residents and increasing their 
potential for success. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background 
 
 
The latest statistics indicate that approximately 50,000 Canadians  will experience a stroke in 
 
 
2010 with an associated cost of approximately $27,500 per stroke (Go et al. 2010).  The burden 
of this disease on our health care system is significant  in terms of costs related to acute care, 
rehabilitation and long-term health care (Luengo-Fernandez, Gray, and Rothwell, 2009; 
Public Health Agency  of Canada,  2009; Public Health Agency of Canada,  1993; Moore, Lix, 
Yogendran,  Martens,  and Tamayo, 2008).  This cost does not take into account the lost 
productivity from disabilities  and premature  death that often accompanies a stroke event. 
The burden of stroke can be decreased in three ways.   The first is preventing  risk factor 
development  by promoting healthy lifestyles  and secondly the controlling of risk factors 
through  lifestyle change and medical management  to reduce the occurrence of stroke.  The 
third means is to rapidly intervene  with medical treatment  when a stroke occurs using 
thrombolytics, medical expertise,  and diagnostic technology.  Health care resources vary 
between regions and rurality. Romanow (2002) noted in his report examining the future of heal 
 
care in Canada that “rural communities often have difficulty accessing primary health care and 
keeping health care providers in their communities, let alone accessing diagnostic services and 
other more advanced treatments” (p. 161). 
Stansbury, Jia, Williams, Vogel, and Duncan (2005) found that “national-level data are rarely 
sufficient to help determine the problems and differences relevant to smaller geographic areas 
and across heterogeneous minority groups” (p. 383). To improve regional-specific prevention 
strategies and the treatment of stroke cases within regions of Canada, cultural and environmental 
data unique to specific geographical areas of Canada should be collected (Wilson et al. 2001; 
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Kapral, Laupacis, and Phillips, 2004).  More regional information on the prevalence of stroke in 
Saskatchewan and the response of the health care system in treating stroke could provide clues to 
the types of interventions needed and the potential for their success. To date, limited information 
is available on the characteristics of stroke management in central and northern Saskatchewan. 
The purpose of this study is to identify the nature of stroke and the management of individuals 
undergoing a stroke or a transient ischemic attack (TIA) diagnosis in a region of Saskatchewan 
that serves both rural and urban populations. It will also compare stroke management in this 
setting with the Canadian Best Practice Recommendations for Stroke Care (CSN and HSFC, 
2010). 
 
 
1.2 Objectives and Research Questions 
 
Question One: What are the characteristics of the people experiencing strokes in Saskatchewan, 
relating to their age, race, gender, and independence, location of their home community, 
documented risk factors, and previous medications to control those risk factors? 
Rationale: The case history obtained through the hospital record will provide a profile of the case 
including age, race, functional independence, risk factors, and prior management of those risk 
factors.  The profile will offer insight into the effectiveness of current primary prevention 
strategies in the community. 
 
 
Question Two: What types of treatments are provided to stroke cases at the Royal University 
Hospital and how do they compare to national guidelines for timeliness and comprehensiveness 
during the acute and hospital phases of care? 
 
Rationale: Best practice recommendations have been developed to guide the management of 
 
stroke care (CSN and HSFC, 2010).  It is useful when establishing local implementations of 
national guidelines to identify consistencies and inconsistencies with national recommendations. 
3 
 
The treatment stroke cases receive  in Royal University Hospital  will be compared  to these 
recommendations for compliance of service  delivery  purposes. 
4 
 
CHAPTER 2: LITERATURE REVIEW 
 
 
2.1 Relevance of Stroke 
 
The latest statistics indicate that 16,000 Canadians will die from stroke in a year and that this 
number represents 15% of all the stroke victims during the same time period (Public Health 
Agency of Canada (PHAC), 2009).  The cost of having a stroke in Canada averages 
approximately $27,500 and 10% of all stroke cases will go on to require long term care for which 
the cost is currently undetermined (PHAC, 2009).  Another 10% of stroke victims will achieve 
full recovery, and the majority will live with disabilities such as the minor weakness of a limb, 
wide ranging cognitive impairments, or the need for comprehensive nursing care and loss of 
bowel and bladder control (PHAC, 2009).  Anecdotally, this national level statistical information 
has historically been assumed to be representative of Saskatchewan residents in the absence of 
evidence to the contrary. 
 
2.2 Types of Stroke 
 
Stroke is divided into two main categories of ischemic including transient ischemic attacks and 
 
 
hemorrhagic strokes that include intracerebral hemorrhage  and subarachnoid  hemorrhage. 
 
 
2.2.1 Ischemic stroke 
 
Ischemic stroke, that includes TIA, is the most common type of stroke is a blockage that cuts off 
blood supply to affected parts of the brain.  Ischemic strokes are often referred to as 
cerebrovascular accidents (CVA) and could be a thrombotic or embolic event.  The effects of the 
blockage are related to the location of the blockage in the brain rather than the source; however 
the source becomes vitally important in identifying the cause for individual management and 
secondary stroke prevention (CSN, 2011). 
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A thrombotic ischemic stroke occurs when a diseased or damaged artery supplying blood to the 
brain forms a clot and pieces of that clot can break away and block a large or small vessel within 
the brain (Mayo Foundation for Medical Education and Research (MFMER), 2013). An embolic 
stroke is caused by a blood clot that has formed elsewhere in the body (emboli) becomes 
dislodged and travels to a cerebral artery (MFMER,  2013).  When an embolic stroke occurs, 
there are almost immediate  neurological and physical deficits.   Emboli may be bacterial  in 
nature,  form as a result of cardiac arrhythmias (atrial fibrillation), vascular repair process, or 
are dislodged vascular plaques (MFMER,  2013). 
A transient ischemic attack (TIA) produces stroke symptoms that resolve when the arterial 
 
blockage is dislodged or dissolved spontaneously without medical intervention.  Hill (2004) 
considers TIA’s to be high risk since 9.5% of those with a TIA will subsequently have a more 
severe ischemic stroke within 90 days.  The opportunity for secondary prevention makes a TIA 
an extremely important medical event (Hill, 2004). 
 
2.2.2 Hemorrhagic stroke 
 
Intracerebral hemorrhagic stroke differs from an ischemic stroke in that it is caused by a ruptured 
blood vessel as opposed to a blood clot.  The ruptured vessel interrupts blood flow and delivery 
of essential nutrients and oxygen to the affected area of the brain. A ruptured blood vessel may 
release blood very rapidly which may lead to a sudden build up in cerebral pressure resulting in 
unconsciousness or death.  Approximately 10-15% of all strokes are hemorrhagic and have an 
estimated 40%-50% mortality rate (Woo et al., 2004; Go et al., 2010). 
Goldstein et al. (2001) determined that “hypertension is a major risk factor for both cerebral 
infarction and intracerebral hemorrhage (p. 281).  Other causes of intracerebral hemorrhages 
include infections, trauma, abnormalities in the blood vessels and blood clotting deficiencies 
6 
 
(Woo et al., 2004; Kiely, Wolf, Cupples, Beiser, and Myers, 1993).  Intracerebral hemorrhages 
are less common than ischemic strokes and only account for approximately 12% of stroke events 
(Woo et at., 2004; Kapral, Laupacis, and Phillips, 2004; Canadian Stroke Network (CSN), 2011). 
Another kind of hemorrhagic stroke is subarachnoid hemorrhage. This is similar to intracerebral 
hemorrhages in that such strokes are caused from a ruptured blood vessel; however these occur 
outside of the brain tissue itself and result in the subarachnoid space surrounding the brain to fill 
up with blood causing rapid loss of consciousness and a poor prognosis for full recovery 
(Reinhardt, 2010). The most common cause is the rupture of a cerebral aneurysm. Aneurysms 
may develop from birth or early childhood and grow very slowly over the years as a result of 
thinning and progressive damage of the artery walls (MFMER, 2013). 
In summary ischemic strokes are the most common type of stroke in both men and women and 
has been linked to many underlying influences known as risk factors. Mortality appears higher 
with those who develop hemorrhagic strokes. 
 
2.3 Risk Factors 
 
A stroke risk factor is something that increases your chances of developing a stroke.  Sometimes 
the risk is a result of personal choices such as smoking, and other times the risk is from non- 
modifiable factors such as age (O’Donnell et al., 2010; Goldstein et al., 2001).  Certain types of 
stroke have slight differences in associated risk factors.  For example, obesity is associated with 
cardiovascular risk leading to ischemic strokes, while hypertension is linked to both ischemic 
and hemorrhagic stroke (Goldstein et al., 2001).  Risk factor analysis is crucial for reducing 
stroke incidence. 
Stroke prevention focuses on risk factors that can be managed through pharmacotherapy and 
those responsive to lifestyle modification (CSN, 2011, O’Donnell et al., 2010, O’Rourke et al., 
7 
 
2004).  For example hypertension and high cholesterol may be controlled through lifestyle 
modification and/or medication.  For the most part, lifestyle adjustments for healthier living 
target lower salt intake, increased exercise, and smoking cessation (CSN, 2011).  The 
identification of the risk factors associated with cardiovascular disease and  stroke have been 
developed over time by studying large numbers of cases and recording their health history into 
data bases to find common patterns (O’Donnell et al., 2010; Wolf et al., 1991; Goldstein et al., 
2001). 
 
 
2.3.1 Non-modifiable risk factors 
 
Non-modifiable risk factors include all risk factors for stroke that cannot be affected by 
individual behaviors.  These factors include age, family history, ethnicity, and disorders for 
which there is no known direct cause. The significance of these factors is outlined in the 
following subsections. 
2.3.1.1: Age 
 
Age is an important risk factor that cannot be modified.  Most individuals who have a stroke are 
over 65, although the average age of stroke victims continues to decrease (Public Health Agency 
of Canada (PHAC), 2010).  The chance of having a stroke approximately doubles for each 
decade of life after age 55, and while stroke is more common among the elderly, an increasing 
number of people under 65 are also having strokes (Asplund et al., 2009).  Telman, et al (2010) 
conducted a study of 656 stroke and TIA cases in Israel from 2001 to 2008 who were under the 
age of 65.  They found the mean ages of TIA cases and stroke cases were 50.6 +/- 7.5 years and 
51.3 +/- 7.6 years respectively.  A limitation of this study was that there was no information 
provided on the frequency of stroke in the over 65 age group who are at high risk of stroke as 
well.  No age is exempt from stroke and when combined with more controllable risk factors such 
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as hypertension, the combination is more important than age alone (Goldstein et al., 2001; 
O’Donnell et al., 2010). 
2.3.1.2: Family history 
 
Family history has been found to be a factor in ischemic as well as hemorrhagic strokes. 
Hereditary factors may be genetic, but environmental and learned lifestyles may also play a part 
(Meschia, 2006; Dichgans, 2007).  Taking learned behaviors into account makes this factor more 
complicated than genetics alone.  Eating, drinking and exercise habits could explain part of why 
strokes may appear to have a familial connection.  Information on the connection between 
parental strokes and strokes experienced by their offspring has been riddled with conflict 
regarding the relative contribution of shared genetic and environmental factors (Kiely, Wolf, 
Cupples, Beiser, and Myers, 1993).  It should be mentioned here that studies searching for a 
genetic link have limited the age of participants to minimize the effect of degenerative changes 
associated with aging on study results. 
In 1993, the Framingham study searched for a familial link and their results were inconclusive 
regarding the role of environmental and genetic influences on familial tendencies for stroke 
(Kiely et al., 1993).  Seven years later, a second finding was published on a familial link from the 
same study.  The number of stroke occurrences by that time gave the researchers the statistical 
power they needed to find a significant association between familial aggregation and stroke.  The 
Framingham study is vitally important in establishing inherited risk because it is the only 
multigenerational study with verified occurrence of parental stroke (D’Agostino, Wolf, Belanger, 
and Kannel 1994; Kiely et al., 1993).  Other studies have had to rely on history taking, death 
certificates or questionnaires (Aboyans et al., 2006; Besthorn, Wahle and Kirch, 2008).  The 
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second Framingham study was able to identify a strong association between parental ischemic 
stroke and offspring ischemic strokes after adjusting for other factors (Seshadri et al. 2010). 
2.3.1.3: Heart disease 
 
Arrhythmias of the heart, valvular disease, previous myocardial infarction, and congenital heart 
defects are noted as significantly increasing the risk of stroke or transient ischemic attack 
(Goldstein et al. 2001; O’Rourke, Dean, Akhtar, and Shuaib, 2004).  Atrial fibrillation alone 
accounts for up to 15% of the strokes seen in Canada, and this number increases up to one third 
over the age of 60 (Heart and Stroke Foundation of Canada, 2010). 
These uncontrollable factors contribute to the individual’s total risk and the greater the number 
of non-modifiable risk factors, the greater the urgency in controlling modifiable risk factors 
outlined in the next section. 
2.3.1.4 Ethnicity 
 
The American Heart Association (2010) summarizes statistics gathered in the United States 
where associations between cardiovascular disease and ethnicity have been recorded (U.S. 
Department of Health and Human Services (USDHHS), Centers for Disease Control (CDC) and 
Prevention, National Center for Health (PNCH), 2006).  In their 2010 statistical update, the 
report on prevalence by ethnicity shows 1.8% for Asians, 2.7% for Caucasians, 3.6% for Afro- 
Americans, and 3.9% for American Indians and residents of Alaska (Go et al., 2010).  The report 
goes on to say that the prevalence rates for American Indians are considered unreliable (Go et al., 
2010).  No prevalence of stoke for Hispanics was reported.  From a public health perspective, the 
National Health and Nutrition Examination Survey (NHANES) identified that the control 
(management) of high blood pressure is not as common in Afro-Americans as it is in Caucasian 
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populations even with the detection and treatment available for hypertension for both groups 
 
(Howard et a!., 2006). 
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2.3.2. Modifiable risk factors 
 
Modifiable risk factors can be controlled or eliminated through lifestyle changes and/or the use 
of pharmaceutical interventions. 
2.3.2.1: Hypertension 
 
Uncontrolled hypertension, defined as blood pressure >140/90 mmHg for an extended period, is 
an important modifiable risk factor for stroke.  Wolf-Maier, (2003) found that 27-28% of 
Canadians suffered from high blood pressure which is an improvement over previous studies 
although it still leaves considerable room for improvement.  Hypertension increases the risk of 
stroke by two to more than four times, independent of other risk factors (Nguyen, Dominguez, 
Nguyen, and Gullapalli, 2010; Haseqawa, 2010; Dobesh, 2006; Powers, Oddone, and Grubber, 
2008).  This increased risk is a result of adaptive structural changes in the blood vessels 
increasing peripheral vascular resistance that may compromise circulation and enhance the risk 
for ischemic events (Woo et al., 2004).   Hypertension also increases the risk of intracerebral 
hemorrhage resulting from damage to the fragile walls of the small arteries inside the deeper 
areas of the brain (Woo et al., 2004). 
 
Controlling hypertension long term can result in a 33% decrease in the risk of stroke (Goldstein 
et al., 2001).  Control of hypertension may require lifestyle changes such as increased physical 
activity, weight loss, alcohol moderation, smoking cessation, lower fat and salt in diets as well as 
the use of blood pressure lowering medications (Canadian Hypertension Education Program 
(CHEP), 2013). Adhering to such a regimen is difficult for many patients and one troubling 
statistic suggests that only about half of those who have prescribed medications actually take 
them consistently (Besthorn et al., 2008; Haseqawa, 2010). 
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In recent years, the role of salt in North American diets and its relationship to hypertension has 
become better understood (CSN, and HSFC, 2010).  Efforts are being made to increase public 
awareness of sodium intake as one of the major contributors to hypertension, and the food 
industry is being encouraged to decrease sodium in prepared foods (Smith-Spangler, Juusola, 
Enns, Owens, and Garber, 2010). 
2.3.2.2: Diabetes 
 
The microvascular and macrovascular complications of diabetes create one of the most 
significant risk factors for ischemic stroke (CSN, 2011).  The Honolulu Heart Program was 
fundemental in establishing the risk of stroke related to diabetes in a study conducted from 1965 
to 1968 involving over 7000 participants and a 12 year follow up period (Abbott, Donahue, 
MacMahon, Reed, and Yano, 1987).  They showed a 2.5 time greater risk of stroke in cases with 
diabetes, but at that time, it was only a suggestion that the reason for the increased risk was due 
to atherosclerosis.  The confirmation of this suggestion came in the years to follow with further 
research (Burchfiel, Abbott, and Curb, 1998).  Chronic high blood glucose was shown to lead to 
the development of atherosclerosis and subsequently stroke risk.  Type II diabetes is preventable 
and can be controlled in many cases through diet, exercise, medication, and weight control 
(Lakka, and Laaksonen, 2007; James, Rigby, and Leach, 2004). 
2.3.2.3: Obesity 
 
Obesity has been recognized for some time as a contributing factor of hypertension.  More 
recently, it is being examined at least in part as an independent risk factor for stroke.  Strazzullo 
(2010) conducted a literature review of prospective studies for their evaluation of obesity in 
relation to stroke events.  Findings showed a positive relationship between overweight, obesity 
and risk of ischemic stroke independent from age, lifestyle, and other cardiovascular risk factors. 
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The relationship between obesity and stroke was further defined with the results of the 
INTERSTROKE study that indicated  “a much stronger association of stroke risk with waist-to- 
hip ratio than with body-mass index” (O'Donnell, 2010, p. 121). 
2.3.2.4: Smoking 
 
The relationship between cardiovascular disease, stroke and smoking has been well established 
in the literature.   In a study by Aboyans et al. (2006) found that current smoking was the 
strongest predictor of the progression of arterial disease.  Smoking is a leading cause of heart 
disease and is a known risk factor for stroke. Smoking is known to raise triglycerides in blood, 
damage endothelial cells that line blood vessel walls, cause thickening and narrowing of blood 
vessels and result in the formation of clots (U.S. Department  of Health and Human Services, 
Centers for Disease Control and Prevention, 2010), 
National Center  for Chronic Disease Prevention and Health Promotion. (2010) Further to 
this, it has been found that inflamatory reactions to smoking are involved in the pathogenesis of 
atherosclerosis (Raupach, Schafer, Konstantinides, and Andreas (2006).  All the studies found 
agreed that smoking is a major risk factor for stroke with the Framingham study finding a 30% 
increase in risk where the MORGAM study found nearly a two fold increase in risk of stroke 
with smoking (Asplund et al., 2009; Elias et al. 2006). 
Smoking cessation programs, legislated restrictions and public awareness programs have had a 
profound effect on attitudes in the last ten years.  The literature shows mixed reviews on the 
success of various programs.  Program located in such areas as remote and lower socioeconomic 
communities have not shown the declines in smoking rates seen in other areas (Sarkar, Lix, 
Bruce, and Young, 2010; Borland et al., 2009;  Zlatev, Pahl, and White, 2010; Evans and 
McCormack, 2012 
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2.3.2.5: Alcohol 
 
The consumption of alcohol in moderate amounts of 1-2 drinks per day has been associated with 
a lower risk of ischemic stroke (Goldstein et al. 2001).  No cause and effect relationship has been 
established between alcohol use and stroke but studies such as The Northern Manhattan Stroke 
Study have shown correlation between moderate use of alcohol and lower levels of low density 
lipoproteins (LDL) and lower blood pressures in individuals consuming small regular amounts of 
alcohol (Goldstein et al., 2001).  There was no evidence to indicate an increased risk of ischemic 
stroke with moderate alcohol consumption however, there is also no evidence for 
recommendations to be made for non-drinkers to initiate consumption, and heavy drinkers 
continue to be encouraged to reduce or eliminate their alcohol use (Lindsay et al., 2010). 
2.3.2.6: Dyslipidemia 
 
Dyslipidemia is a term used to describe excessive levels of blood cholesterol that create plaque 
deposits on blood vessel walls (PHAC, 2012; O’Rourke, Dean, Akhtar, and Shuaib 2004).  These 
fatty deposits can occur within the brachiocephalic or internal carotid arteries and cause 
narrowing of the artery that decreases blood flow to the brain and increases the risk of blockage 
(Go et al., 2010; PHAC, 2012; O’Rourke et al., 2004).  The presence of this buildup is generally 
not treated unless the individual also has physical symptoms associated with it (O’Rourke et al., 
2004).  When this occurs, it can be surgically corrected through endarterectomy or by stenting 
(O’Rourke et al., 2004).  More commonly, elevated cholesterol levels are treated medically 
through the use of statins, a type of medication to reduce low density lipoprotein (LDL) levels 
(Amarenco et al. 2009). 
There has been controversy regarding the effect of fat intake as it relates to levels of cholesterol 
in the body and the ensuing relationship to cardiovascular disease and stroke (Gillman, Cupples, 
15 
 
Millen, and Ellison, 1997; Sauvaget, Nagano, Hayashi, and Yamada, 2004).  Participants in the 
Women’s Health Initiative diet modification trial made changes to diet alone, reducing the 
amount of dietary fat and increasing the intake of fruits, vegetables, and carbohydrates (Howard 
and Van Horn et al., 2006). The women were followed for greater than 8 years and yet 
researchers were still unable to show a decrease in cardiac disease or stroke.   As noted by the 
researchers, it was possible that the lack of effect on the cardiovascular system may be a result of 
a combination of elevated cholesterol and other risk factors such as a lack of exercise (Howard 
and Van Horn et al., 2006).  It should also be noted that in Japanese studies, where increased 
dietary fat intake did not appear to be associated with ischemic stroke, the normal diet is low in 
cholesterol and therefore, the increase in fat intake seen in those populations is still lower than 
most North American diets as noted by Gillman (1997) and Boden-Albala (2009).  The studies 
suggest that a low fat diet is more useful in the context of a healthy balanced lifestyle and the 
risk of heart disease and/or stroke need to be managed on multilevels concurrently. 
 
High cholesterol and heart disease has been well accepted for some time, and the majority of 
research, especially in North America shows a positive relationship between high levels of LDL 
and stroke (Goldstein et al., 2001; Hachinski et al., 1996; Strazzullo et al., 2010; Amarenco et al., 
2009). 
 
2.3.2.7: Metabolic syndrome 
 
The risk factors for metabolic syndrome include hypertension, glucose intolerance, dyslipidemia, 
and abdominal obesity.  Of these factors, high blood pressure is considered one of the key 
components (Boden-Albala and Elkind et al., 2009). Each factor carries with it it’s own risk of 
causing a stroke.  In combination, these same factors carry an even greater risk making the 
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control of each risk factor even more crucial (Boden-Albala and Sacco, et al., 2008; Cronin and 
 
Kelly, 2009; Rodriguez-Colin et al., 2009). 
 
Combinations of specific risk factors carry a higher risk and have been grouped into a category 
called metabolic syndrome.  This clustering of risk factors serves as a predictor for 
cardiovascular disease and diabetes, in turn may prove to be a predictor of stroke as well (World 
Health Organization (WHO), 2006; Boden-Albala and Sacco, et al., 2008; Cronin and Kelly, 
2009).  The World Health Organization (WHO) definition of metabolic syndrome requires the 
presence of diabetes mellitus, impaired glucose tolerance, impaired fasting glucose or insulin 
resistance and two of; 1) blood pressure greater than 140/90; 2) dyslipidemia with specific limits 
for triglycerides as well as high and low density lipoproteins for men and women; 3) central 
obesity determined by waist circumference and 4) microalbuminuria as found in urine output 
(WHO, 2006). 
The prevalence of the syndrome increases with age and the number of components involved. 
Cronin and Kelly (2009) estimate the relative risk of stroke to have a “5-fold increase in stroke 
incidence for those having all 5 components” (p. 3).  This does not in any way minimize how 
each risk factor is managed but does imply emphasis on patient education for the compounding 
effect of multiple risk factors. 
2.4 Global View of Stroke 
 
The major cohort studies assessing the characteristics of stroke originated in Europe, North 
America and Asia with less comprehensive information from Australia, Africa and South 
America.  In 1978 results from several significant studies identifying cardiovascular risk factors 
and incidence were presented at the Bethesda Conference in 1978 (Keys, 1980).  Two prominent 
studies were the Framingham Heart Study (Massachusetts), and the Seven Countries study 
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(Finland, the United States of America, Japan, Greece, Yugoslavia, Italy and the Netherlands). 
Findings at this conference showed that rates of cardiovascular death were declining or 
stabilizing in some populations while increasing in others.   On closer inspection of the studies it 
became apparent that there was wide variation and inconsistency in the definitions and 
populations studied within these investigations.   As a result of the findings presented at the 
Bethesda Conference, the World Health Organization (WHO) recognized the need for long term 
monitoring of mortality, morbidity and risk factors associated with stroke occurrence.  As a 
consequence, the WHO MONItoring of trends and determinants in CArdiovascular disease 
(MONICA) Project was undertaken across four continents in the 1980s and 1990s, and paralleled 
similar longitudinal studies that took place in the United States of America.  MONICA sparked 
the interest of cardiologists, neurologists and epidemiologists around the world that in turn 
generated new research into treatment options and preventive strategies.  This was followed by 
the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study. 
2.4.1 MONICA and MORGAM 
 
The MONICA study involved a random population health survey to collect information on 
cardiovascular risk factors for stroke from 38 populations in 21 countries and encompassed 10 
years of data collection on individuals 35 to 64 years of age (Tolonen et al., 2002).   Information 
was predominantly collected from European countries where collection continued beyond the 10 
year study period and in some countries continued until 2002.  Population health survey data was 
compared to death rates recorded in hospital data bases and death records to verify the 
information gathered in the survey (Tolonen et al., 2002). 
The MONICA project demonstrated that stroke rate decline observed in some populations and 
countries, as initially described at the Bethesda conference, were attributed to both improved 
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hypertension management and improved stroke treatment (Tolonen et al., 2002). The project also 
demonstrated that the proportion of variation in stroke trends observed between different 
populations could be explained by the variation of the trends in risk factors between the various 
populations (Tolonen et al., 2002). 
The MORGAM study was a follow-up study to the MONICA project that collected further 
information on cardiovascular and stroke risk factors.  It was initiated in 19 countries and 
involved the collection of data from 51,703 men and 41,992 women.  Eight European countries 
which were part of the original MONICA study participated.   Researchers who took part in the 
MORGAM study had the following hypotheses (1) the risk factors have similar effects in all 5 
regions; (2) the risk factors have similar effects for men and women; and (3) the risk factors have 
similar effects for age groups <45 years, 45 to 54 years, 55 to 65 years, and >65 years at baseline 
(Asplund et al., 2009).  Baseline assessments were completed and the participants were followed 
prospectively for all causes of mortality, non-fatal coronary disease, and strokes.  The 
MORGAM study was completed in 2009 and was self-reported as being the largest prospective 
study of stroke events performed to date (Asplund et al., 2009).  The results of the MORGAM 
Study showed that serum levels of cholesterol were not a significant predictor of stroke (Asplund 
et al, 2009).  However, higher serum levels of high density lipoproteins (HDL) were found to 
decrease the risk of stroke during the follow-up period of the study (Alplund et al, 2009). 
Results from the study indicated that “for each 10-mm Hg increase in blood pressure, the risk of 
stroke increased by 23% to 29% however, these findings varied between populations and 
regions” (Asplund et al. 2009, p. 2323).  The increased risk with smoking also varied greatly 
between sub-cohorts.  They concluded that there are many similarities and differences between 
regional groups which may be explained by other more subtle influencing factors such as 
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regional socio-economic conditions, physical activity, and dietary factors that were not captured 
in the data (Asplund et al., 2009).  These influences may have modified the impact of the 
medically defined stroke risk factors of hypertension and dyslipidemia (Asplund et al., 2009). 
Asplund et al, (2009) also found there were many reasons why stroke risk factors would have 
varying impact in different populations in the study and that the major confounders are age, sex 
and geography in addition to genetic variations and socioeconomic status. 
The MONICA and MORGAM studies are two of the largest stroke risk factor studies completed 
with multinational, multi-ethnic, populations.  One of the greatest limitations with large studies 
such as these is that the less developed countries that possess less communication and testing 
(equipment) technology are not able to contribute on the same level as more technologically 
advanced countries, limiting the ability to generalize results to all populations. 
2.4.2 Sino-MONICA Study 
 
The Sino-MONICA study was a prospective study of peole living in China that investigated the 
incidence and prevalence of stroke and myocardial infarction following the methodology of the 
MONICA study.  Men and women ages 35 to 65 were enrolled from 16 provinces of China and 
then followed for a 7 year period (Wu et al., 2001).  The study was launched in 1987 following a 
2 year pilot project, and results indicated the prevalence of stroke in men to be 59/100,000 and 
 
52/100,000 in women (Wu et al., 2001).   Wu et al. (2001) found that the prevalence of stroke 
was higher than results of other populations in the MONICA study while the prevalence of 
myocardial infarction was lower.  The study also found that there were much higher rates of 
stroke in the smaller rural regions where the lack of technology and formal health systems could 
be found and that this may have had an influence on differences noted (Wu et al., 2001). 
2.4.3 Framingham Heart Study 
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An important study in the understanding of risk factors associated with cardiovascular disease 
and stroke was the Framingham Heart Study which began in 1948 in the United States.  It began 
as a cohort study of a Massachusetts community with several thousand healthy individuals 
participating in physical examinations and lifestyle interviews that would later be used to analyze 
for common patterns pertaining to the development of cardiovascular disease (National Heart, 
Lung and Blood Institute (NHLBI), 2013.  Individuals returned every two years to update their 
history and be re-examined.  The study has continued to expand and now includes offspring of 
the original cohorts as well as new residents of Framingham (NHLBI, 2013; Petrea et al., 2009). 
The investigators monitored age, systolic blood pressure, use of antihypertensive medication, 
diabetes, cigarette smoking status, history of cardiovascular disease (coronary artery disease, 
heart failure or intermittent claudication), atrial fibrillation and left ventricular hypertrophy (Elias 
et al., 2004; Kannel et al., 1981).  The study identified hypertension as a pivotal risk factor for 
stroke, with substantial increase in stroke risk when combined with co-morbidities (Kannel et al., 
1981).  Although the majority of the cohort was Caucasian, the risk factors have proven to be 
valid even among other ethnic groups although the patterns of distribution may vary by ethnicity 
(Howard et al., 2006).  The Framingham Heart Study has become the most widely used reference 
study for stroke risk analysis, and has been used extensively in international and national 
guidelines for cardiovascular disease prevention (Asplund et al., 2009).  The Framingham Risk 
Score was developed initially to determine the 10 year risk for developing congestive heart 
disease including myocardial infarction and coronary death (D’Agostino et al., 1994).  The risk 
factors used in the Score were age, total cholesterol, HDL cholesterol, systolic blood pressure, 
treatment for hypertension, and cigarette smoking.  These indicators were later re-tested for their 
accuracy in predicting cerebrovascular disease and as a result, the Framingham Stroke Risk 
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Profile was developed (Wolf, D’Agostino, Belanger, and Kannel, 1991; D'Agostino, Wolf, 
Belanger, and Kannel, 1994; Elias et al., 2004).  The profile was later refined to recognize the 
effects of treatment and the lowering of risk associated with the control of risk factors 
(D’Agostino et al., 1994). 
The results of this study allowed researchers to develop a risk analysis scoring method which 
could be applied to populations with similar American profiles but cannot necessarily be applied 
to larger and more diverse populations (Boden-Albala and Sacco et al., 2008). 
2.4.4 Northern Manhattan Study (NOMAS) 
 
The Northern Manhattan Study (NOMAS) is a study of the population of Washington Heights in 
 
Northern Manhattan, New York (Sacco et al., 1998).  It is an ongoing study, which began in 
 
1990, and is based in the Neurological Institute of Columbia Presbyterian Hospital.  The study 
has enrolled over 4,400 people from the surrounding community.  The overall goal of NOMAS 
was to investigate stroke risk factors in different race and ethnic groups.  NOMAS utilized 
interviews with patients, and other neurological examinations to gather information on multiple 
risk factors for stroke including obesity, dietary fat intake, and metabolic syndromes.  NOMAS 
is an ongoing information base allowing concomitant prospective studies to take place which 
focus on a specific risk factor to follow among residents who have never experienced a stroke for 
a period of time or until a specific number of people have had a stroke event (Boden-Albala and 
Sacco, et al. 2008; Boden-Albala, Elkind, and White, 2009; Willey et al. 2009; Elkind et al. 
2010).  NOMAS continues to be a unique source of population information for stroke and 
associated risk factors including the role of ethnicity and lifestyle.  The ethnic groups represented 
in this cohort include Caucasians, Afro-Americans, and Hispanics living in the same community. 
This ethnic diversity in the participants has provided additional information that was not 
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available in the Framingham studies and showed a two to three-fold difference in the incidence 
of stroke in Afro-Americans and Hispanics over Caucasians (Sacco et al., 1998).  In later 
research Sacco, et al. (2005) found an increased incidence of stroke in the Afro-Americans and 
Hispanic population over the Caucasian population even after adjusting for hypertension, 
diabetes, and education. 
2.4.5 The National Institute of Neurological Diseases and Stroke 
 
The National Institute of Neurological Diseases and Stroke (NINDS) is a division of the National 
 
Institute of Health (NIH) in the United States (NINDS, 2013).  Since 1977 NINDS has sponsored 
 
28 Phase 3 trials to evaluate treatments of stroke for 44, 862 stroke participants.  The trials were 
designed to test drugs, devices, surgery, and behavioral intervention in stroke prevention, acute 
treatment, and rehabilitation (Howard, VanHorn, et al., 2006). Sponsored studies have found that 
in the black stroke population there was less control of hypertension than in the white population. 
They hypothesized that with increased hypertension awareness and treatment that the higher 
incidence rates among blacks might diminish over time (Howard, VanHorn, et al., 2006)  One 
NINDS trial of note is the Reasons for Geographic and Racial Differences in Stroke 
(REGARDS) study (Howard, Cushman et al, 2005). This is an prospective population based 
enquiry intended to be of a national scope although recruitment of participants is concentrated in 
the southern American states.  The study is designed to investigate the geographical and ethnic 
factors associated with stroke for the future development of culturally and geographically 
sensitive stroke information.  Subjects for this study were enrolled from 2003 to 2007 and are 
contacted every six months by phone to enquire about stroke symptoms.  Results from 
REGARDS are limited at present; however it has the potential to provide much needed 
information. 
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2.4.6 Canadian Research 
 
For many years, stroke research in Canada has been concentrated in the eastern provinces, and 
for the most part was initiated by either pharmaceutical companies through clinical trials or by 
stroke neurologists scattered across the country.  What was missing was an organized method of 
fitting the pieces of information into a more comprehensive body of evidence of Canadian 
populations at risk.  In the last ten years, the face of stroke in Canada has become more clearly 
defined and strategies have been put in place to improve the inter-relatedness of information 
gained (Canadian Stroke Network (CSN), 2013). 
The emergence of the CSN in 2000 brought together researchers, academics, front line clinicians, 
students, government, industry and the non-profit sector in a collaborative organization.  The 
CSN is funded by the Networks of Centres of Excellence (NCE) with additional funding from 
private industry.  In 2004 the CSN partnered with the Heart and Stroke Foundation of Canada 
(HSFC) to create the Canadian Stroke Strategy (CSS).  The purpose of CSS is to promote an 
integrated multidisciplinary approach to stroke prevention, treatment and rehabilitation (CSN, 
2013).  The goal of the CSS was to support and promote each province and territory in the 
development of a provincial strategy. 
A major initiative of the CSN was the development of a registry to gather stroke data from major 
stroke centres across the country (Kapral, Laupacis, and Phillips, 2004).  Saskatoon participated 
in the initial phase which began in 2000 and collected data for a 12 month period.  The registry 
gathered extensive data to characterize the entire stroke event from onset to completion of in- 
patient medical care, allowing investigators to obtain a clear understanding of the proportions of 
stroke-types and the prevalence of risk factors and quality of care (Kapral et al., 2004).  This 
initial phase of the registry required patients and family to give written informed consent, which 
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proved to be a barrier to enrollment and created bias in participant selection (Kapral et al., 2004). 
Stroke victims who could not write their name due to literacy or physical barriers were 
eliminated, family members were not always available or willing to provide consent, and 
mistrust of the system eliminated many from cultural groups who were fearful of how the 
information would be used despite the explanation of de-identification by trained professionals 
(Tu et al. 2004).  The second phase of the registry required sites collecting information to be 
financially supported by their local institutions, and at this point Saskatoon was not able to 
participate.  The information gathered in the first phase and subsequent data collection phases, 
primarily from Ontario, has provided a wealth of information regarding useful guidelines for 
stroke care and areas for further research (Kapral, et al., 2004). 
In 2006, the Canadian Best Practice Recommendations for Stroke Care were introduced (CSN 
and HSFC, 2006)  The development of this document included an extensive review of 
international research and published evidence based best practice recommendations and 
guidelines.  The literature was reviewed by working groups consisting of stroke experts in 
Canada and the literature categorized by evidence levels using the AGREE tool as outlined in the 
first edition of the document (CSN and HSFC, 2006; Lindsay et al., 2010).  The 
recommendations have undergone bi-annual updates since that time to include new information 
and make the guideline more comprehensive (CSN, 2011; Lindsay et al., 2010).  The 
recommendations provided in the guideline come with performance measures from which health 
centres are able to gauge the success of their actions to advance stroke care.  Two of these 
performance measures from the acute phase of care were selected for further investigation in this 
research.  The recommendations also include core performance measures for an indication of 
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overall performance of stroke care from which one measure was selected for evaluation in 
this research. 
More recently, the CSN funded and conducted an audit of stroke care called, The Quality of 
Stroke Care in Canada using the data capture methodology developed for the Registry of the 
CSN (CSN, 2011).  This research was based on a chart audit of 38,210 case charts from 295 
hospitals across Canada for the 2008-2009 period.  The audit included 13 Saskatchewan 
hospitals for a total of 1385 cases.  This information was used to describe the quality of stroke 
care currently provided to stroke cases across Canada and to make recommendations on how it 
could be improved. 
Manitoba has done some very interesting work with data linkages and in the process has 
provided new information on the incidence and prevalence of cardiovascular health risk and 
stroke in their aboriginal populations (Moore et al. 2008; Elias, O’Neil, and Sanderson, 2004; 
Jebamani, Burchill, and Martens, 2005).  Their ability to link data bases has increased the local 
understanding of the impact of stroke in Manitoba. and such approaches to study through 
routinely collected health information could be useful in assessing regional and remote 
populations in other provinces.  Remote populations in all provinces have the potential to be 
under represented with the prominence in provinces with less funding and already poor 
representation. 
In summary this review of the literature identified several risk factors with the occurrence of 
stroke in populations from different parts of the world.  Little is known about the relevance of 
this information for Saskatchewan populations.  The information profiling the stroke case in 
Saskatchewan is missing from the planning of programs and services for stroke prevention and 
treatment.  The studies reviewed show that in addition to the more common risk factors for 
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stroke, ethnic and geographical factors are important to identify when characterizing stroke 
morbidity.  The sampling of stroke cases presenting to Royal University Hospital, the designated 
stroke centre for the central and northern regions of Saskatchewan, will help to identify the 
uniqueness of the regional information and the potential needs and population characteristics that 
can be used for a more encompassing regional stroke surveillance system. 
2.5 Conceptual Model of Acute Stroke Care and Management 
 
While prevention of stroke through better management of lifestyle factors remains a critical part 
of reducing stroke burden, there are characteristics within a stroke event that can be helpful in 
the identification of future prevention and management strategies for stroke. Demographic, 
personal and acute management concepts are important areas in the assessment and management 
of an acute stroke event.  The demographic variables establish the basic information of age and 
gender as well as providing information on the approximate length of journey for each case. 
Personal information looks at the health profile of individuals prior to the stroke event based on 
their risk factors and the medications prescribed to control these risk factors.  Independence at 
the time of the stroke is used to compare to independence at discharge for an estimate of the 
impact of stroke in the sample.  The variables included in the acute management category 
measure the performance of the Royal University Hospital in the treatment of acute stroke. 
The figure 2.1 describes the typical intervention and management of a stoke event and the 
information that is useful in improving localized response to a stroke event.  There are two 
phases that should be examined in developing strategies for future stroke care that are reflective 
of the local characteristics and needs in stroke management. The immediate care phase identifies 
the health characteristics of the population being admitted to hospital with stroke, examines the 
use of interventions, and measures the performance of the institution in meeting national 
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recommendations for stroke care.  The second stage involves the use of local information to 
supplement information provided through national sources.  This information is for use in the 
improvement of care through evidence based modifications to local programs. 
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Immediate Care 
 
 
 
DEMOGRAPHIC INFORMATION 
 
Age, gender, ethnicity, home location, 
& method of transportation to hospital 
 
 
 
 
 
PERSONAL INFORMATION 
 
Risk factors, medications, type of 
stroke, & previous independence 
 
 
 
 
ACUTE MANAGEMENT 
 
Registration to test times, diagnostic 
tests, & length of stay and discharge 
destination. 
 
 
Strategies for Planning Response to an Acute Stroke 
 
 
 
 
 
Locally gathered regional  information National  information on which 
current  programs are based 
 
 
 
 
 
 
 
 
Confidence  level in the use of 
national  information and 
guidelines 
RUH 
performance 
measure 
i   l 
Additional regional 
information to 
supplement  previous 
knowledge and support 
 
Figure 2.1 
 
Conceptual model of stroke care and management 
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CHAPTER 3: METHODOLOGY 
 
3.1 Study Design 
 
This is a retrospective descriptive study design involving the review of stroke case hospital 
records. 
3.2 Study Population and Setting 
 
The population selected for this study was all stroke cases over the age of 55 years, who were 
admitted to the Royal University Hospital (RUH), Saskatoon, Saskatchewan for treatment April 
1, 2009 to March 31, 2010 formed the population for the study. The Royal University Hospital 
represents the regional stroke centre for the central and northern regions of Saskatchewan 
because of the availability of neurologists, neurosurgeons, and diagnostic services required for 
stroke management. For this reason and because it is representative of other similar regional 
stroke centres across Canada, the Royal University Hospital was selected as the site for this 
research project.  During a recent audit of stroke management in Canada, Royal University 
Hospital admitted more than 30% of all strokes in Saskatchewan to its’ emergency department 
and in-patient units (Canadian Stroke Network (CSN), 2011). 
3.3 Ethical Approval 
 
Approval was received from the University of Saskatchewan Biomedical Research Ethics Board 
November 23, 2011 and from the University of Saskatchewan Department of Research and 
Innovation (Saskatoon Health Region) November 30, 2011. 
3.4 Study Sample 
 
Following ethics approval a request was submitted to the Strategic Health Information and 
Performance Support (SHIPS) department of the Saskatoon Health Region requesting the 
identification of all cases admitted to RUH that met the inclusion criteria outlined in Table 3.1 
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for the period of April 1, 2009 to March 31, 2010.  An explanation of the International 
Classification of Disease (ICD) codes used in the inclusion and exclusion criteria is contained in 
Appendix D.  Briefly, cases under the age of 55 were excluded as well as cases admitted to RUH 
who are not residents of Saskatchewan.  The age exclusion for this study follows the framework 
for the identification of those individuals at sufficiently increased risk of stroke to warrant 
vigorous risk factor management developed by the Framingham study (Elias and Sullivan et al., 
2004; Wolf et al., 1991; D`Agostino et al., 1994).  Following the guidelines for definition of 
stroke as outlined in the World Health Organization Monitoring Cardiovascular Risk (MONICA) 
trial, any cases readmitted with 28 days with a diagnosis of a stroke or a TIA were excluded to 
distinguish one event from another (Tolonen et al., 2002).  A total of 425 cases met the inclusion 
criteria. Due to financial restrictions, a sample of 200 cases was selected for analysis through the 
random selection function of the Statistical Program for the Social Sciences (SPSS). 
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Table 3.1 
 
Inclusion / exclusion criteria 
 
Inclusion Criteria Exclusion Criteria 
Men and women >55yrs admitted with 
 
ischemic stroke, intracranial hemorrhage, and 
subarachnoid hemorrhage. 
Men and women <55yrs of age 
Stroke as defined by ICD codes: 
 
-All acute stroke - 160 (exclude 160.8), 161, 
 
163 (excluding 163.6), 164, 167.6, and H34.1, 
 
163 (excluding 163.8), 164 and H34.1 
(including acute but ill-defined 
cerebrovascular) 
-subarachnoid  hemorrhage - 160, 161 
 
-intracerebral    hemorrhage -G45(excluding 
 
G45.4) 
 
-transient ischemic attack – H34.0 
Stroke as defined by ICD codes: 
 
160.8, 163.6, 163.8, and G45.4 
Residents of Saskatchewan All cases who are not Saskatchewan 
 
residents. 
First stroke event admission within a 28 day 
 
period 
Men and women admitted with a second 
 
stoke event within 28 days of the first 
stroke event. 
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3.4.1 Refinement of the sample 
 
Of the 200 randomly selected cases, three cases were identified as not meeting the criteria for 
inclusion in the study.  The first case was admitted with a diagnosis of H1N1 and subsequently 
found to have possible small regions of infarction or demylinating disease on computed 
tomography (CT).  The second case was admitted under cardiology and had an incidental finding 
of an old infarct on CT.  This case underwent an angiogram and subsequent bypass surgery with 
no further investigations by neurology and the third case was diagnosed with cerebral 
hemorrhage secondary to traumatic head injury and was transferred out of province for surgical 
treatment. 
The diagnosis for three of the cases were coded as ischemic as well as hemorrhagic due to 
hemorrhagic transformation of their original ischemic stroke.  In these cases, the hemorrhagic 
diagnosis was not used in the analysis.  The remaining 197 cases were included in the analysis. 
Two additional cases were coded as both intracerebral and subarachnoid hemorrhage.  It was 
determined that the original location of the bleed then spread to involve a second area.  The 
originating location of hemorrhage was used in these cases. 
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3.5 Operational Definitions 
 
Table 3.2 
 
Definitions of variables examined in acute stroke management 
 
Category Variable Operational Definition 
 
 
 
 
Demographic 
-age------------------ 
 
-gender,------------- 
 
-ethnicity------------ 
 
-home location----- 
 
 
 
 
 
 
 
 
 
 
-transportation------ 
->55 years 
 
-male or female 
 
Causasian, Aboriginal, Other 
 
-Saskatoon:Resident of Saskatoon city 
Urban/other: cities outside Saskatoon with CT 
scanners, 
rural -all regions without CT scanners 
remote rural:Athabasca, Mamawetin Churchill 
River, and  Keewatin Yatthe. 
 
 
-ambulance, 
private transportation 
air ambulance 
 
Personal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Personal (cont’d) 
-risk factors--------- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
medications--------- 
physician report of – 
 
hypertension (yes/no/unknown), diabetes 
(yes/no/unknown), dyslipidemia 
(yes/no/unknown), obesity (yes/no/unknown), 
alcohol abuse (yes/no/unknown), and smoking 
(yes/no/unknown), and atrial fibrillation 
(yes/no/unknown) any in the following 
categories reported: 
 
anti-hypertensive (yes/no/unknown), 
clopidogrel (plavix) 
(yes/no/unknown),,Coumadin (warfarin) 
(yes/no/unknown),, Acetylsalicylic 
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-type of stroke------ 
 
 
 
 
 
 
 
 
independence 
level------------------ 
Acid(yes/no/unknown),  , oral glycemic (any) 
 
(yes/no/unknown),, Insulin, (any injectable) 
(yes/no/unknown),, anti-lipid (any) 
(yes/no/unknown). 
 
 
-ischemic or hemorrhagic as recorded in the 
physician assessment and confirmed in the 
reported on admission history 
 
 
 
 
independent prior to stroke (yes/no) 
 
 
 
Acute Management 
-Registration to test 
times----------------- 
diagnostic tests----- 
 
 
 
-length of stay----- 
 
 
-discharge 
destination---------- 
 
 
phlebotomy (minutes) 
CT Scan (minutes) 
 
 
transthorasic echocardiogram (yes/no) , carotid 
ultrasound (yes/no), CT angiogram (yes/no), 
Holter monitor (yes/no), and MRI(yes/no) 
 
 
-number of hospital days from admission to 
discharge as per the hospital record. 
 
 
 
-home, rehabilitation, long term care, home 
hospital, deceased in hospital. 
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3.6 Data Collection and Tools 
 
The collection of data began December 1, 2010 and was completed January 12, 2011. The data 
collection tool used for this study is provided in Appendix A. The process of abstracting data 
was performed as follows: 
1.   An abstractor was trained by the researcher to collect case information from the stroke 
case record using the data collection tool in Appendix A. 
2.   Health record numbers provided by SHIPS were used to locate the selected cases for the 
sample.  The Health Records department of RUH provided 10 charts per day for the 
abstracter to review and record information into an individually numbered data record 
coinciding with each chart.  Cross referencing of study data record to the health record 
for each case was recorded on and independent cross reference list.  A separate 
unidentified list of postal codes and ID numbers was made to classify the health region 
from which each case originated as required by the University of Saskatchewan Ethics 
Department. 
3.   Study data records were scrutinized for completeness and 23 charts had to be recalled to 
clarify information from the original health record. 
4.   Each record was given a unique identifier and a master list was developed linking this 
number to the health record.  A list was then made of the health regions corresponding to 
the postal codes obtained from the health record. 
5.   Data abstraction was deemed complete January 12, 2011 after which the original list of 
records provided by SHIPS, the cross reference list of hospital chart and study data 
record, as well as the list of postal codes and identification numbers were destroyed using 
a shredding machine. 
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As per the University of Saskatchewan protocol, the research data will be held by the thesis 
supervisor, Dr. Lalita Bharadwaj, in a locked cabinet in the College of Public Health for a 
minimum of five years. 
3.6.1 Performance Measures 
 
The Canadian Best Practice Recommendations for Stroke Care (CSN and HSFC, 2010) provides 
performance measures to assess the impact of implementing the recommendations for stroke 
care.  The following 4 performance measures were selected for analysis based on the availability 
of information in the health record with one being a core indicator.  Table 3.3 provides an 
overview of the guidelines, their performance measures and the variables used for evaluation. 
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Table 3.3 
 
Definition of the guideline, performance measures and the operational definitions. 
 
Guideline Performance measure Variable and Operational 
definition 
1: All suspected stroke patients: complete 
blood count (CBC), electrolytes, 
creatinine, urea, glucose, international 
normalized ratio (INR), partial 
thromboplastin time (PTT), thyroid- 
stimulating hormone (TSH), fasting lipid 
profile, creatine Kinase (CK), troponin 
test. 
Acute blood work, including routine chemistry, 
electrolytes, hematology and coagulation should 
be conducted as part of the initial evaluation 
Registration to phlebotomy 
time / measured as the time 
from registration to the time of 
phlebotomy. 
2: All patients with suspected acute stroke 
or transient ischemic attack should 
undergo brain imaging (MRI or CT) 
immediately. 
The proportion of stroke patients who receive a 
brain CT/MRI within 60 minutes of hospital 
arrival. 
Registration to CT time / 
measurement of time in 
minutes from the time of 
registration to the time of CT 
scan. 
3: Core indicator – as an indication of 
overall institutional performance not 
attached to a guideline. 
Distribution of discharge locations (dispositions) 
for acute stroke patients from acute inpatient 
care to:  home (with and without services); 
inpatient  rehabilitation (General or specialized); 
long term care; and to palliative care (each 
stratified by stroke type and severity). 
Discharge destination / home, 
rehabilitation, long term care, 
home hospital, or deceased in 
hospital. 
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3.6.2 Analysis 
 
Statistical analyses were performed using SPSS for Windows Version 17.0 (SPSS Inc., Chicago, 
Illinois, USA).  Descriptive statistics including age, gender, type of stroke, etc. were calculated 
and used for reporting the results.  Statistics used to describe the data included means (standard 
deviation), frequencies and percentages. For proportion of stroke by health regions, the 
population as described in the annual report of health regions for 2011 was used for the 
denominator. 
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CHAPTER 4: RESULTS 
 
4.1 Description of Demographic 
 
4.1.1 Description of the Population Admitted to RUH for Stroke and TIA 
 
The results of the study showed that the diagnosis of stroke was divided comparatively even 
between men and women, with men (100) representing 51% and women (97) representing 49% 
of the sample.  The mean age for men was 74.46 years + 10.3 SDA.  This was slightly lower than 
 
the mean age of 79.08 years + 9.7 SD was found in females. The most frequent type of stroke 
 
was an ischemic stroke (72%) followed equally by TIA or intracerebral strokes (12% each). 
Figure 4.1 indicates that the percentage of men and women admitted to Royal University 
Hospital for stroke. More women than men were treated for a TIA or a subarachnoid hemorrhage 
while more men than women were likely to be admitted with an intracerebral hemorrhagic 
stroke. The distribution of ischemic stroke was slightly higher in men (53.0% versus 47%). 
 
 
 
Women Men 
 
80 
 
70 
 
60 
 
50 
 
40 
 
30 
 
20 
 
10 
 
0 
Ischemic Stroke TIA Intracerebral Subarachnoid 
 
 
Figure 4.1 
Proportion of stroke type by gender of 197 randomly selected cases from study chart audit Royal 
University Hospital 2009/2010 
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Table 4.1 
 
Frequency of stroke sub-types by age and gender 
 
Gender and Age Ischemic 
 
Stroke 
 
 
 
n = 143 
Transient 
 
Ischemic 
 
Attack 
n = 23 
Intracerebral 
 
Hemorrhage 
 
 
 
n = 24 
Subarachnoid 
 
Hemorrhage 
 
 
 
n = 7 
Total 
 
 
 
 
 
n = 197 
Women (n=97)      
55-65 8 1 1 2 12 
66-75 12 3 3 0 18 
76-85 30 4 5 2 41 
>85 17 7 1 0 25 
Men (n=100)      
55-65 18 2 5 1 26 
66-75 25 1 2 1 29 
76-85 18 4 6 1 29 
>85 15 1 1 0 17 
 
 
4.1.2 Stroke Cases by Residence 
 
Of the total 197 cases included in the study, just over 80% were living independently at the time 
of their cerebrovascular accident with, 78 (49.3%) residing in Saskatoon.  Fifty six (35.4%) of 
cases were living independently in rural areas, while 12 (7.6%) lived independently in urban 
centres outside of Saskatoon and 12 (7.6%) lived in remote rural areas.  A total of 39 (19.8%) 
cases from all areas required partial or full care prior to the qualifying cerebrovascular accident. 
Transportation to hospital was categorized into three groups: ambulance, personal vehicle, and 
air ambulance services.  Of the 197 cases included in the study, the majority 136 (69.0%) arrived 
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to hospital by ambulance.  Fifty cases (25.4%) arrived by personal transportation and 11 (5.6%) 
arrived via air ambulance services.  Data describing the gender, age, transportation, community 
and independence of the cases are provided below in Table 4.2. 
Table 4.2 
Description of demographic characteristics 
 
Characteristic Category- 
Demographic 
Frequency 
 
(n = 197) 
Percentage 
 
(%) 
Gender Male 
 
Female 
100 
 
97 
50.8 
 
49.2 
Age in years 55-65 
 
66-75 
 
76-85 
 
85+ 
38 
 
47 
 
70 
 
42 
19.3 
 
23.9 
 
35.5 
 
21.3 
Type of transport Ambulance 
 
Private 
 
Air ambulance 
136 
 
50 
 
11 
69.0 
 
25.4 
 
6.6 
Community Saskatoon 
 
Urban/other 
 
Rural 
 
Remote rural 
106 
 
13 
 
66 
 
12 
54.8 
 
6.6 
 
33.5 
 
6.1 
Independence  Prior to 
 
Stroke 
Yes 
 
No 
158 
 
39 
80.2 
 
19.8 
 
 
 
 
4.1.3 Description of health region representation by total population 
 
The total population for each health region is included in their annual reports to the Minster of 
Health.  Using these population numbers, the representation from each region was calculated as a 
per capita percentage to discover if this would change the ranking of highest to lowest 
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representation of stroke.  The Saskatoon Health Region showed the highest percentage of cases 
in the study sample while Heartland had the highest percentage of cases per capita (Saskatoon 
Regional Health Authority, 2011).  Athabasca Health Authority had the lowest number of cases 
in the sample but when used as a representation of the region’s population, this region was the 
higher per capita percentage of either Kelsey Trail, Prairie North, or Parkland (Athabasca Health 
Authority Reports, 2006; Prince Albert Regional Health Authority, 2011; Prairie North Health 
Region, 2010; Kelsey Trail Health Region, 2010; Heartland Health Region, 2010; Mamawetan 
Churchill River Health Region, 2010; Keewatin Yatthé Regional Health Authority, 2010). 
Table 4.3 shows the number of people arriving at Royal University Hospital from each of the 
health regions. In the table, urban centres are included in their respective health regions and 
Saskatoon includes the rural areas of the region.  Of the 197 cases, 130 (62.9%) lived within the 
Saskatoon Health Region representing just over half of the cases identified during the time 
period between April 1, 2009 and March 31, 2010.  Thirteen of cases (7%) arrived to hospital 
from the urban communities of Melfort, Prince Albert, North Battleford, Lloydminster, and 
Kindersley.  Sixty six (33%) of cases arrived from rural communities.  Twelve cases arrived to 
hospital from remote rural communities located in the Mamawetan Churchill River, Keewatin 
Yatthé, and Athabasca Health Regions 
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Table 4.3 
 
Representation by Health Region 
 
Region Frequency 
 
n = 197 
Percent of Study 
 
Cases per Region 
Study Cases as a Percentage of 
 
Health Region Population 
 
(# per 1000) 
Saskatoon 
(rural plus one urban centre) 
130 62.9 44 
Prince Albert Parkland 
(rural plus one urban centre) 
5 2.5 6.4 
Prairie North 
( rural plus 2 urban centres) 
14 7.1 19 
Kelsey Trail 
( rural plus 1 urban centre) 
9 4.6 21 
Heartland 
(rural) 
27 13.7 63 
Mamawetan Churchill River 
(remote rural) 
5 2.5 22 
Keewatin Yatthé 
(remote rural) 
6 3.0 27 
Athabasca 
(remote rural) 
1 .5 22 
 
 
4.2 Personal Characteristics 
 
There were two categories that could not be used for analysis due to the minimal amount of data 
available.  The first was ethnicity where there were only two charts with documentation.  The 
second category was obesity where there was no reference to body weight in 138 of the charts 
(70%), another 45 (23%) had a documented history of no obesity and 13 (7%) documented cases 
of obesity. 
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4.2.1 Description of Population Risk Factors 
 
Table 4.4 presents the frequency of common risk factors associated with a stroke case. 
Hypertension was identified as the most frequent risk factor with (81%) of cases having a 
documented diagnosis of hypertension.  Forty six percent of cases had recorded dyslipidemia, 
29% had cardiac artery disease, and 27% had diabetes.  Of all the cases identified, 31 were 
smokers (16%), and an additional 5% of cases reported having quit smoking in the last five years 
or less.  Seventy nine percent of cases were non-smokers. 
There were 37 cases (19%) that had a family history of stroke prior to their event.  Of the 197 
cases, 35 (18%) had a recorded history of at least one episode of atrial fibrillation and nearly one 
third had a noted history of previous stroke or TIA. 
Twenty eight (14%) of the cases were noted to have had previous cardiac surgery; 12% had 
reported heart attacks and 7% (13) had reported congestive heart failure.  Of the total 197 cases, 
7% (13) reported alcohol abuse. 
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Table 4.4 
Personal risk factors reported in 197 cases of stroke between April 1, 2009 and March 31, 2010 
at Royal University Hospital* 
 
Risk Factor Frequency Percentage 
 
 n = 197  % 
hypertension 160 81 
dyslipidemia 91 46 
cardiac artery disease 57 29 
diabetes 55 28 
atrial fibrillation 35 18 
previous stroke 35 18 
previous TIA 28 14 
cardiac surgery 28 14 
myocardial infarction 24 12 
congestive heart failure 13 7  
alcohol abuse 13 7  
smoking- current 31 16 
- no-stopped <5 years 11 5  
family history 37 19 
 
* Percentage does not equal 100 as many cases had more than one risk factor 
 
 
 
4.2.2 Description of Gender Differences in Relation to Risk Factors 
 
The literature indicates that multiple risk factors increase the risk of cardiovascular disease and 
stroke although the exact combination of factors is not clear (WHO, 2006; Boden-Albala and 
Sacco, et al. 2008; Cronin & Kelly, 2009).  All agree that hypertension is the single most 
important factor and this was also in the sample taken from Royal University Hospital where 
81% of the sample had a positive history as seen in Table 4..  The other major factors include 
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dyslipidemia, found in 46% of the sample and diabetes that was found in 27% of the sample 
(Cronin & Kelly, 2009; WHO, 2006).  Abdominal obesity was also named as a critical factor but 
was not obtainable in the sample due to lack of documentation.  Rodriguez-Colon et al. (2009) 
found the more metabolic syndrome components an individual has (up to 5 components), the 
higher the risk of a stroke. 
The sample indicates that a large proportion of cases had 3 to 5 risk factors although it was not 
possible to identify if these risk factors were in fact the ones identified in the literature. The 
sample shows a larger number of men in the lower age categories with greater than 5 risk factors 
where women have more risk factors with age.  Gender differences were minimal in relation to 
age.  The average age for men having a stroke was 74 with a range of 55-95 years; while the 
average age for women was 79 with a range of 56-96 years at the time of their stroke. Figures 4.2 
and 4.3 indicate the number of cases by age range and gender with three to five and greater than 
five risk factors per case. 
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Figure 4.2 Frequency of risk factors for stroke (>5 or 3 to 5) in males 
 
 
 
Figure 4.3 Frequency of risk factors for stroke (>5 or 3 to 5) in females 
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4.2.3 Description of medications used to treat risk factors 
 
The medication reconciliation data base provided on admission was utilized to identify currently 
filled prescriptions for each case in the study.  There were 35 cases of previous stroke and 28 
cases of previous TIA in the case histories.  Of the previous stroke cases, all were currently 
prescribed an antiplatelet or anticoagulant medication to prevent a second occurrence where only 
78.6% of the previous TIA cases were currently prescribed any of these same medications for 
secondary prevention.  One hundred forty two (89%) of the 160 cases with a diagnosis of 
hypertension were currently taking a medication identified as anti-hypertensive.  Eighty cases 
(40%) were utilizing acetylsalicylic acid daily, and statins were used in 63 (67%) of the 94 cases 
with a documented history of dyslipidemia.  An anticoagulant (Coumadin) was prescribed in 14 
of the cases (7%) for use in the treatment of atrial fibrillation. 
Case history data demonstrated that 55 (28%) of the cases were identified as having diabetes 
with 42 (76%) currently being treated with antiglycemic medication.  Results show that of the 
known cases with diabetes, 32 (58%) were taking an oral glycemic medication, and 13 (24%) 
were taking an injectable form of insulin.  These two groups of diabetic medications can be used 
concurrently as demonstrated by 3 cases who were treating their disease with both insulin and an 
oral glycemic medication. 
4.3  Acute Management of Stroke Cases at Royal University Hospital 
 
4.3.1 Description of arrival times as it pertains to therapy limitations 
 
The time from stroke onset to arrival at hospital was grouped into five categories for the purpose 
of analysis.  These include:  i) 0-4.5 hr – eligible time for thrombolytic therapy; ii) 4.5-6 hours – 
improvements in process might have the potential to shorten the time to treatment; iii) 6-12 hours 
– interventional therapies may be an option for treatment up to 9 hours; iv) 12-24 hours; v) >24 
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hours useful for assessment of the magnitude of delays and possible gaps in education.  See 
 
Figure 4.4 for the summary of arrival times. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Proportion of participants with different elapsed time from symptom onset to arrival 
at Royal University Hospital emergency room 
 
 
 
Arrival times noted in Figure 4.4 include all methods of transport. Of the 197 cases, 46 were 
treated elsewhere prior to transport to RUH or arrived at hospital greater than 48 hours after the 
stroke occurred and were therefore not included in this analysis of acute admissions.  Of the 
remaining 151 cases seeking acute treatment, 20 (13%) received tPA. 
Overall, sixty six of the 197 cases (33%) arrived at the emergency department in less than 4.5 
 
hours following the onset of their symptoms.  These individuals represent the percentage of cases 
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that were potential candidates for thrombolysis.  Two thirds of cases did not arrive early enough 
for treatment.  Fifty one cases (26%) reached hospital in the first 90 minutes past the treatment 
window of 4.5 hours.  Thirty four (17%) cases arrived within the 6 to 12 hour time frame, 15 
(8%) arrived to hospital within 12 to 24 hours and the remaining 31 (16%) arrived well out of the 
treatment window in greater than 24hours post symptom onset. 
The arrival to hospital times were then examined based on the case’s home community (SHR, 
urban, rural, or remote rural community).  Fifty two of cases (42%) from the City of Saskatoon 
arrived at hospital within the 4.5 hour treatment window while 2 (15%) from urban centres 
outside Saskatoon arrived in this same time window.  Twenty cases (30%) residing in rural 
communities arrived at Royal University Hospital in time to treat.  There were no cases from 
remote rural areas that arrived within the 4.5 hour treatment window.  Twenty six of the cases 
(24%) from Saskatoon missed the treatment window by less than 90 minutes as did 5 (39%) from 
urban centres outside of Saskatoon, 18 (27%) from rural areas, and 2 (17%) from remote 
communities.   The majority of cases arriving from remote rural communities (8 or 67%) arrived 
between 6 and 12 hours post onset of symptoms, which was nearly four times longer than the 
17% of cases arriving from rural Saskatchewan.  Twenty three percent of the cases coming from 
urban centres outside of Saskatoon did not reach a RUH for greater than twelve hours.  Both the 
urban centres located in rural areas and the cases originating in the City of Saskatoon, 
demonstrated 15% of cases arriving to hospital more than 24 hours after the onset of symptoms. 
This percentage was slightly higher (18%) coming from rural areas, and lower (8%) from remote 
rural areas.  Figure 4.5 below shows the length of time it took individuals to reach Royal 
University Hospital from each of the study communities. 
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Figure 4.5 
 
The percentage of stroke/TIA cases from each of the study communities and the length of time it 
took individuals to reach Royal University Hospital 
 
 
 
4.3.2  Description of Hospital Response to Acute Stroke Admission 
 
The time taken by staff to facilitate treatment when the case reaches hospital can be very 
important to outcomes.  The recorded start times for computed tomography (CT), 
electrocardiogram (ECG), and phlebotomy reflect the response of staff to an acute stroke case. 
Forty seven cases (24%) were transferred from other sites and had computed tomography 
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completed prior to transfer.  These cases were not included in this portion of the analysis to avoid 
bias.  Other cases may not have had a CT done prior to arrival at hospital, but had an ECG (22 
cases) or phlebotomy (23 cases) done at another facility or from a previous admission indicated 
by the number of cases included in the analysis.  Tests completed prior to registration were not 
used in the analysis.  Table 4.5 shows the maximum, minimum, mean and standard deviation for 
registration to test time. 
Table 4.5 
 
Elapsed time from registration in emergency at Royal University Hospital to test time 
 
 
Correlate Minimum Maximum Mean Std Deviation 
Registration to CT 
 
n= 150 
0 min 6 hr 04 min 1 hr 01 min 1 hr 29 min 
Registration to ECG 
 
n= 175 
0 min 12 hr 10 min 1 hr 25 min 2 hr 2 min 
Registration to Phlebotomy 
n= 174 
0 min 7 hr 17 min 1 hr 6 min 1 hr 24 min 
 
 
 
The time it takes to complete these tests is crucial in determining the cases eligibility for 
treatment with tPA which is currently the only non-surgical treatment available for acute stroke. 
The time from registration to the time tPA is given is referred to as the door-to-needle time.  The 
Best Practice Guidelines for Stroke recommend a target time of less than 60 minutes. Cases 
reaching RUH within the treatment window of 4.5 hours were included in this analysis. 
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TABLE 4.6 
 
Door to needle times for tPA 
 
Door-to-Needle Time in Minutes 
 
 
 n Minimum Maximum Mean Std. Deviation 
Minutes 20 29 214 70.05 44.519 
 
 
Many cases underwent tests during their hospitalization to establish the etiology of the stroke. 
These tests included a second CT scan (n=84), CT angiogram (n=68) to assess plaque formation 
in the carotid arteries, a carotid ultrasound (n=126) for those who would not be able to tolerate a 
CT angiogram, and echocardiogram (n=144) to assess the heart as a possible source of 
cardioembolic emboli, an MRI (n=42) to detect small strokes, and a Holter monitor (n=130) to 
assess the rhythm of the heart and detect paroxysmal atrial fibrillation.  Table 4.7 summarizes the 
in hospital tests completed for the sample population. 
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TABLE 4.7 
Investigative Tests Completed during the Hospitalization Period 
 
Category Frequency 
n = 197 
Percent 
 
 
% 
CT scan 197 100 
 
CT angiogram 
 
68 
 
35 
 
carotid ultrasound 
 
126 
 
64 
 
echocardiogram 
 
144 
 
73 
 
MRI 
 
42 
 
21 
 
Holter monitor/telemetry 
 
130 
 
66 
 
2
nd 
CT scan 
 
84 
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The discharge destination provides some insight into the independence of the individual on 
hospital discharge. Table 4.8 indicates 72 of the cases (37%) returned to their own homes 
following their hospitalization, and 32 cases (16%) were transferred directly to rehabilitation for 
their physical disabilities.  A total of 30 (15%) required long term care following their 
cerebrovascular accident, while 39 (20%) were transported back to a hospital in their home 
community for continued medical and nursing care, and 4 (2%) were transferred to palliative 
care at another hospital in the city.  There were 20 (10%) patients who did not survive their 
stroke. 
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Table 4.8 
Discharge destination of study population 
 
Category Frequency 
 
N = 197 
Percent* 
 
% 
Home 72 36.5 
Rehabilitation 32 16.2 
Long term care 30 15.2 
Home hospital 39 19.8 
Deceased in hospital 20 10.1 
Palliative care Saskatoon 4 2.0 
 
 
 
Of the cases in the study arriving to hospital within the time to treat with thrombolytics, 20 cases 
(12%) were administered tPA, the drug therapy.  Table 4.9 indicates that of these cases, 45.0% 
were able to return home, and another 20% were transferred to a rehabilitation program where 
they may have been able to return home at some point.  Another 35% were transferred to long 
term care on discharge or to their home hospital for ongoing nursing care.  One case was not 
independent prior to admission.  Their ages ranged from 58 to 91 years of age with a mean of 
76.7 years + 8.4 STD. 
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Table 4.9 
 
Discharge destination following hospitalization for cases receiving acute thrombolytic therapy 
 
Gender Home 
 
 
n=9 
Rehabilitation 
 
 
n=4 
Long term 
care 
n=3 
Home 
hospital 
n=4 
Total 
 
 
n=20 
Male 7 2 1 2 12 
Female 2 2 2 2 8 
 
 
 
4.4 Performance Measures from the Canadian Best Practice Recommendations for Stroke 
as they Relate to Study Results 
Performance measures were developed to monitor the impact of implementing the best practice 
recommendations on the quality of patient care and/or patient outcomes (CSN, 2011).  Four 
study variables were selected for comparison to these performance measures. 
4.4.1  Performance Measure One 
 
Acute blood work, including routine chemistry, electrolytes, hematology and coagulation should 
be conducted as part of the initial evaluation (Lindsay et al. 2009) 
The current research showed the 174 of the 197 cases had phlebotomy done for routine blood 
work within the first 7 ½ hours after registration with a mean time of just greater than one hour 
and standard deviation of 1 hour 20 minutes.  The remaining 23 cases were transferred from 
another facility where phlebotomy was done.  Results from other health facilities are not retained 
in charts at Royal University Hospital although they are used for initial assessment where 
possible.   In some cases, physicians noted the use of referring facility results where in other 
cases, results were noted with no documentation of their origin and the same results were not 
found in the RUH case chart.  It was not possible to accurately assess the number of cases where 
out of hospital results were used in the initial assessment.  This may have affected the study 
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results where the phlebotomy time recorded was done in follow up to those from another facility 
resulting in longer than expected times for phlebotomy. 
4.4.2  Performance Measure Two 
 
Electrocardiogram and chest X-ray should be completed, especially where the patient has a 
clinical history or evidence of heart disease or pulmonary disease (Lindsay et al. 2009). 
Electrocardiograms (175) were performed on admission with a mean time of one hour twenty 
five minutes and a maximum time of 12 hours 25 minutes.  The minimum time is recorded as 0 
minutes because it was done within RUH immediately prior to the completion of the registration 
process.  The remaining 22 cases registered with a completed ECG from another facility as noted 
in the physician assessment. 
4.4.3  Performance Measure Three 
 
All patients with suspected acute stroke or transient ischemic attack should undergo brain 
imaging (MRI or CT) immediately (Lindsay et al. 2009).  The more specific measurement is the 
proportion of stroke patients who receive a brain CT/MRI within 60 minutes of hospital arrival. 
There were 61 cases where CT was completed within 60 minutes representing 31% of cases. 
Another 28 (14%) were completed at a referring hospital prior to admission leaving 55% of cases 
waiting greater than one hour.  Not all cases would have been considered acute and the study did 
not collect information on whether the cases were considered stroke or not. 
4.4.4  Performance Measure Four 
 
Percentage of patients discharged to their home or place of residence following an inpatient 
admission for stroke (Lindsay et al. 2009). 
There were 70 cases that were documented as returning to their place of residence at discharge 
from the hospital.  Of the cases admitted, 80% were documented as living independently, but 
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only 36.5% were considered independent at discharge.  It appears that for 43.5% of the cases 
who were considered independent on admission, the ability to live independently was lost. 
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5.1  Question One 
CHAPTER 5: DISCUSSION AND CONCLUSIONS 
 
What are the characteristics of the people experiencing strokes in Saskatchewan, relating 
to their age, race, gender, independence, location of their home community, risk factors, 
and previous medications to control those risk factors? 
A discussion of the similarities and differences between people experiencing stroke in 
Saskatchewan and those observed in National and International studies will be considered in the 
following sections. 
5.1.1  Demographic description of stroke cases 
 
National and international information outlining major risk factors for stroke currently guide 
prevention and treatment strategies in Saskatchewan. The information gathered through the 
performance of this research is uniquely local, however much of the information gathered with 
respect to risk factors and types of stroke support the national and international findings.  This 
unique local information is important if it can be used to improve programs and planning that 
result in improved stroke outcomes. 
Travel distances to hospital and area of residence are factors unique to Saskatchewan residents. 
These factors are variable among residents and will affect the time to diagnosis and treatment of 
stroke.  Although these factors are not considered valuable for comparative purposes in this case, 
travel distance to hospital and area of residence are important demographic features to gather to 
facilitate the development of regional programs. The results of this study support much of this 
information provided at a national level with respect to risk factors and types of strokes (CSN, 
2011; Kapral et al., 2002). 
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5.1.1.1  Age and gender 
 
Age is a non-modifiable risk factor for stroke with an increase in incidence associated with aging 
(Asplund et al., 2009; CSN, 2011; Elias et al., 2004; O’Donnell et al., 2010).  Men and women 
were found to be affected equally by stroke in the population included in this study.  Subtle 
gender differences were observed in relation to age when the age was grouped into 10 year 
increments.  For example, 30 female stroke cases were observed in the age range of 76 to 85 as 
compared to 18 male stroke cases observed in the same age range.  Conversely, in the 66 to 75 
year age range, there were more than double the number of male cases (25) as there were females 
(12). The higher number of strokes at a younger age in men in this study is similar to the 2009 
Canadian audit of stroke and could have implications for programs targeting younger men in 
awareness and prevention programs (CSN and HSFC, 2010).  Although these differences are not 
fully understood, recognition of gender differences may help with interventional treatment 
programs. 
Gender differences have been noted by stroke type (De Rooij, et al., 2007; O’Donnell et al, 2010; 
CSN, 2011).  In the present study, only seven cases of subarachnoid hemorrhage were observed 
and of these cases there did not appear to be any gender differences.  Intracerebral hemorrhage 
was noted in 24 of the stroke cases admitted to the RUH. The sample of intracerebral 
hemorrhages was small and a larger sample would be required to make any inference as to 
possible causes for the difference however, a higher proportion of men than women in the 55 to 
64 year age range was noted in the study.  No other notable differences were observed in the 
other age ranges utilized in this study. 
Several studies have investigated gender differences in stroke (CSN, 2011; D’Agostino et al., 
 
1994; Elias et al., 2004; O’Donnell et al., 2010).  The Canadian Stroke Audit demonstrated that 
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of all stroke cases studied here, there was an equal distribution of stroke incidence among men 
and women.  For example, of the stroke cases reviewed in the audit, 50% of the cases were men 
and 50% were women.  More specifically the CSN results from Saskatchewan showed 45% were 
men and 55% were women (CSN, 2011).  In the present study, similar findings were observed 
where of the total stroke cases studied, 53% were men and 47% were women.  Gender 
differences appear to be related to sample size rather than regional differences.  Similar findings 
were reported in an extensive Danish study which included over forty thousand cases.  Olsen, 
(2011) reported that of the 40,000 cases, 52% were men and 48% were women with a similar 
average age. 
Age and gender are significant factors to evaluate when studying stroke for the purpose of 
treatment, education and prevention (Go et al., 2010; Luengo-Fernandez et al., 2009).  One major 
reason for evaluating gender differences is to focus and inform awareness campaigns and 
prevention programs.  The description of this regional stroke sample supports the national 
information available that shows no difference in gender overall.  Primary prevention education 
as well as awareness and interventional programs that can be gender neutral in their planning 
with a focus on younger men to reduce the potential for multiple risk factors as well as programs 
to educate women on the reduction and control of their risk factors as they age. 
5.1.1.2  Stroke type 
 
The risk factors for stroke differ between stroke sub-types which makes the information of what 
type of stroke is most common extremely important in prevention programs and in the planning 
of acute stroke care (Kapral et al., 2004; Lindsay et al., 2010; Young and Hachinski, 2003).  The 
majority of stroke cases in this research (84%) were ischemic rather than hemorrhagic which is 
consistent with national data shown in national information where 80% were ischemic (CSN, 
62  
2009; PHAC, 2009).  Of these ischemic strokes, 12% were classified as TIAs which is somewhat 
lower than the CSN findings of 17%.  The lower percentage of TIAs admitted to RUH could 
possibly be contributed to the presence of a stroke prevention clinic for referral as an alternative 
for admission to hospital.  Not all centres in the CSN findings had access to a stroke prevention 
clinic as an alternative to admitting the case for diagnostic testing.  Data from the emergency 
room and the SPC would need to be examined in conjunction with admission records to gain a 
clearer understanding of the actual rate of TIAs accessing treatment at RUH. 
Women in this study were admitted for TIA twice as often as men during the study period.  This 
result differs from national results for reasons that are unclear.  Two possible explanations could 
include referrals of more men to the SPC than women, or that more women sought help for their 
symptoms than did men.  Further research that included the emergency room records of stroke 
referral as well as admission are needed to provide adequate information to form conclusions. Of 
the 23 TIAs admitted, the only observable difference between genders was that in the women 
over 85 years, there were seven cases compared to one male case.  The overall results for 
hemorrhagic strokes was 16% compared to 15% reported in national statistics and 16% in the 
national audit of 2008/2009 (CSN, 2011; PHAC, 2009).  Of the hemorrhagic strokes, there were 
three times as many intracerebral as subarachnoid strokes and the number of subarachnoid 
hemorrhages (SAH) was higher in women than found in men.  Conversely, the research indicated 
a slightly higher percent of men than women with ICH.   All of the results for hemorrhagic 
strokes concur with previous Canadian research indicating that there are no regional differences 
in this category of stroke (CSN and HSFC, 2010; PHAC, 2009). 
 
Table 5.1 and 5.2 show the stroke types by gender found in this study and those reported by the 
 
Canadian Stroke Audit (CSN, 2011) in their results. Small differences are observed, but in 
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general the sample taken for the Canadian audit supports the results in this study.  Gender 
differences are seen in TIA where this study demonstrated twice as many women as men 
admitted.  Since 2008/09 when the CSN audit took place, and prior to this study in 2009/10, the 
introduction of a stroke prevention clinic was made that may have impacted the number of 
admissions for TIA.  The Canadian audit results included more than 38,000 cases as taken from 
chart reviews while the study at RUH included 197 cases 
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Table 5.1 
 
Stroke type by gender as found in the chart review of cases at Royal University Hospital 
 
Current study 
results RUH 
Ischemic 
Stroke 
Transient 
Ischemic 
Attack 
Intracerebral 
Hemorrhage 
Subarachnoid 
Hemorrhage 
Total 
% of Total 
Strokes 
72 12 12 4 100 
% Occurring 
in Women 
47 67 42 60 49 
% Occurring 
in Men 
53 33 58 40 51 
 
 
 
Table 5.2 
 
Stroke type by gender as found in the Canadian Stroke Audit 
 
Canadian 
Audit 
Ischemic 
Stroke 
Transient 
Ischemic 
Attack 
Intracerebral 
Hemorrhage 
Subarachnoid 
Hemorrhage 
Total 
% of Total 
Strokes 
63 17 11 5 100 
% Occurring 
in Women 
49 51 47 60 50 
% Occurring 
in Men 
51 49 53 40 50 
 
 
 
5.1.1.3  Independence 
 
The impact of lost independence has far reaching effects on families, communities and the health 
care system (PHAC, 2009; PHAC, 1993).  Independence prior to the acute stroke event was 
determined by recording living conditions prior to hospital admission.  In the present study 80% 
of cases were previously living independent lives.  This sample result is supported by other 
studies that gathered prospective data using a tool that measures a person's daily functioning 
(Luego-Fernandez et al., 2009).  This includes specifically their activities of daily living and 
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mobility.  These studies also found that the majority of stroke cases were living independently 
prior to admission to hospital (Mahoney and Barthel, 1965; Luengo-Fernandez et al., 2009). 
Caro, Huybrechts, & Kelly (2001) found in a study of 1446 acute stroke cases that 82.9% had a 
Barthel Index score of 100 representing independent living prior to admission.  Information on 
the independence of cases prior to their stroke is necessary for calculating the impact of stroke in 
care costs and lost productivity.  The impact of stroke in Saskatchewan through lost 
independence is unknown and although it is acknowledged, more research is required to 
accurately measure the scale of that impact. 
5.1.1.4  Home location – area of residence 
 
The location of residence prior to stroke has an impact on the ability to reach a RUH in time to 
receive thrombolytic therapy.  The majority of cases were observed to come from Saskatoon. 
Saskatoon is an area with the greatest population and residents within this region have access to 
the RUH through available transport.  Rural health regions with no large centres capable of 
diagnostic imaging such as Heartland had a higher representation than those with diagnostic 
equipment and the ability to treat stroke with thrombolytic therapy such as Parkland.  The remote 
health regions had minimal representation in the sample.  This could be explained by the lower 
overall population base in these regions or the inadequacies of transportation and services 
leading to fewer cases being referred to a stroke centre for acute treatment.  Sparsely populated 
remote rural areas as defined in Appendix C have no large urban centres equipped to treat acute 
strokes.  Additionally the lack of CT scanners in these areas makes treatment, even by telehealth 
impossible. 
Saskatchewan’s Health Regions have substantial differences in total population and ability to 
reach RUH for treatment as seen in the representation by health region of stroke cases admitted. 
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There are few hospitals in the sample regions able to provide CT scanning and only one with 
neurology and neurosurgery services.  Remote rural regions have limited access to acute stroke 
treatment as seen in the number of admissions from these regions to RUH.  Stroke prevention 
strategies to control risk factors are vital in these regions where treatment is not readily available. 
New approaches are needed to treat stroke in remote rural regions when strokes do occur.  Plans 
to introduce telehealth in these areas have not yet come to fruition and the lack of medical 
imaging remains a barrier as does transportation times.  Much work and planning is needed to 
provide adequate solutions to these problems. 
5.1.1.5  Transportation to hospital 
 
Transportation to hospital is a key factor in the treatment of stroke (Broadley and Thompson, 
 
2003).  The type of transportation used to reach hospital has a key impact on the limited time 
available to treat ischemic strokes with thrombolytic therapy and interventional therapies for 
hemorrhagic strokes.  In this study sample, the majority of cases arrived by ambulance, one 
quarter by private transportation and less than 10% by air ambulance.  In the Canadian Stroke 
Network (CSN) 2008-2009 audit of Canadian hospitals, a similar number of stroke cases were 
reported to arrive to hospital by ambulance (CSN, 2011).  Although 69% of the cases arrived at 
RUH by ambulance, only 33% were within the treatment window of 4 ½ hours that would make 
them eligible for thrombolytic therapy. 
A study of 284 acute stroke cases in South Australia reported 35% of cases reached hospital in 
less than 3 hours (Broadley and Thompson, 2003).  They found that location at stroke onset was 
the only independent predictor of time to admission and that those living within metropolitan 
areas reached hospital in time to qualify for thrombolytic therapy more often than those in rural 
areas. Since the Broadley and Thompson (2003) study, advances have been made in public 
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awareness, the treatment window has been increased, and protocols have been put in place to 
expedite stroke cases to hospital (Lindsay et al., 2008).  Despite these improvements, our 
percentage of cases arriving at hospital within the treatment window is less than those in the 
Australian study.  With nearly 54% of the study cases coming from the urban centre of 
Saskatoon, our performance could be improved.  Saskatchewan has major geographic challenges 
in overcoming the unacceptable transportation times currently experienced in its remote rural 
regions and will require creative approaches to surmount the issues. 
Stroke cases reaching hospital just outside the therapeutic window, between 4.5 and 6 hours after 
symptom onset, represent cases where quicker action might change outcomes, increase treatment 
options and be a target for further examination  Early treatment of stroke symptoms increases the 
possibility of better long term outcomes and decreases the costs associated with long term care. 
Delays in treatment are costly in both physical and mental deficits as well as the financial 
burdens placed on the system related to extended hospital stays and long term care (Caeiro, 
Ferro, & Figueira, 2012; Geffner, Soriano, Perez, Vilar, & Rodrigues, 2012).  Increasing the 
availability of CT scanners in centres throughout the study regions combined with telehealth 
capabilities in these centres would provide the expertise of a neurologist to oversee the 
administration of thrombolytic therapy prior to transport for continued management under their 
care.  Increased awareness of the urgency required in seeking medical attention could decrease 
transportation times by encouraging people in the recognition of symptoms and to call an 
ambulance as opposed to private transportation. 
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5.1.2 Description of personal information 
 
5.1.2.1  Risk factors and their relationship with age and gender 
 
Hypertension, dyslipidemia, diabetes, and atrial fibrillation are risk factors that can be controlled 
with medications.  Age, previous stroke or TIA are examples of risk factors that cannot be 
changed while others such as smoking, obesity, and alcohol abuse can be controlled through 
lifestyle modifications.   A single risk factor for stroke is much more manageable than multiple 
factors sometimes categorized as a metabolic syndrome (Cronin & Kelly, 2009; Boden-Albala 
and Sacco, 2008).  Zhang et al (2011) found in a meta analysis of European and US studies that 
as people age, the incidence and prevalence of stroke increases with men generally having a 
higher incidence than women.  Studies to date have not correlated the number of risk factors with 
age and gender. 
This study found that 39% of the stroke cases were between the ages of 55 and 75 years.  A trend 
was also observed between age and number of risk factors for stroke.  Sixty-one percent of 
stroke cases within the ages of 55 to 75 were found to have three or more risk factors and two 
cases presented with a total of eight risk factors. It was also noted that 17% of cases between the 
ages of 55 and 65 presented with more than three risk factors. Seventy-six percent of men within 
this age group and 24% of women presented with more than 3 risk factors.  In the present study it 
was also observed that the percentage distribution of risk factors for men and women varied with 
age group.  Men in this research had higher risk than women from age 55 to 75 with the highest 
risk from age 65 to 75 based on the number of risk factors per case.  After age 75 the risk in 
women surpassed that of men and remained higher with the greatest risk for women between age 
75 and 85.  No sources were found in the literature to support this observation. 
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From the total cases identified during the study period, the four most common risk factors 
identified were hypertension, dyslipidemia, cardiac artery disease, and diabetes.  Hypertension 
has been identified in other studies as a major factor in the risk of stroke and was confirmed in 
this cohort as were dyslipidemia, cardiac disease and diabetes (WHO, 2006).  In addition to these 
major risk factors, nearly one quarter of these cases were also smokers or had quit within the 
previous five years. 
5.1.2.2  Medication use 
 
Medication use was gathered to indicate the pharmacological management of risk factors for 
stroke.  Medications examined in the study were specific to known risk factors for stroke and 
these included most predominantly those for hypertension, diabetes, atrial fibrillation, and 
previous TIA or stroke.  Patient history on admission demonstrated that not all participants were 
using medications for the treatment of stroke associated risk factors.   There are a number of 
possibilities to explain this finding that would include adherence issues, under prescribing by 
physicians, or errors in documentation.  Osterberg and Blaschke (2005) recognize that “the full 
benefit of the many effective medications that are available will be achieved only if patients 
follow prescribed treatment regimens reasonably closely” (p. 487).  O’Rourke et al., (2004) 
suggests that family physicians and specialists need to aggressively treat the risk factors for 
stroke through pharmaceutical interventions where other interventions such as lifestyle 
modifications have not been or are not yet effective.  The many possibilities for what appears to 
be the under treatment of risk factors were not explored in this research but a lack of adherence 
to prescribed medications or under prescribing could both explain the lack of treatment. The use 
of medications for the control of risk factors included in this study will be discussed in the 
context of the individual risk factors. 
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5.1.2.3  Hypertension 
 
Hypertension has been shown to be a major risk factor for stroke in the literature (Robitaille et 
al., 2012; Roger et al., 2011).  The INTERSTROKE study was the first large standardized case- 
control study of risk factors for stroke in which countries of low and middle income were 
included and all cases completed neuroimaging (O’Donnell et al. 2010).  O’Donnell et al showed 
that hypertension was the most important risk factor for all stroke subtypes.  In the present study, 
the majority of cases, 88%, were documented with a previous diagnosis of hypertension.  Of 
these cases, 12% did not have a currently filled prescription for any hypertensive medication 
suggesting uncontrolled blood pressure. 
The Canadian statistics in the recent stroke audit demonstrated that 64% of stroke cases had 
existing hypertension. The current research revealed similar results of hypertension in 
comparison to other studies (CSN, 2011; Elias et al., 2004; Go et al., 1997; O’Donnell et al., 
2010; Robitaille et al., 2012). In this study population it was determined that 81% of the cases 
have a previous history of elevated blood pressure.  The Saskatchewan sample results are well 
above the Canadian findings and should be further investigated for underlying causes and the 
results to be shared with health care professionals involved in primary prevention.  In previous 
studies the underlying causes of hypertension were reported to include sedentary lifestyles, 
smoking, obesity, excessive alcohol consumption, high fat diets, and excessive salt intake 
(PHAC, 2009; James et al., 2004).  With the exception of smoking and obesity, these factors 
could not be examined in this study however, the high rate of hypertension in this population 
warrants further enquiry into the predominant Saskatchewan causes of hypertension and 
solutions for their reduction. 
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5.1.2.4  Diabetes, cardiac artery disease, and atrial fibrillation 
 
The microvascular and macrovascular complications of diabetes create one of the most 
significant risk factors for ischemic stroke (CSN, 2011).  Fifty five cases were reported to have 
diabetes in the stroke population studied. Daily injectable insulin or oral medications were taken 
by 42 of the diabetics identified. Three diabetics were found to be taking both insulin and an oral 
medication.  It is a possibility that those individuals not taking medications could have been 
considered borderline diabetic controlling their disease with diet or they could be non-compliant 
with medications prescribed for them (Krueger, Felkey, and Berger, 2003). Further information 
on the status of diabetes or medication usage was not collected in this research.  Future studies 
looking at stroke and diabetic control could look at more specific measure of diabetic control by 
collecting information on blood glucose levels at the time of admission or a heamoglobin A1C 
measuring longer term control.  However these data provide insight into the level of diabetic 
control in the stroke cases identified and provide rationale for further investigation into glycemic 
control at the time of admission to hospital and also to the effectiveness of disease control 
measures. 
Diabetes and cardiac artery disease (CAD) had comparative representation in this study sample 
to that of the national findings (CSN, 2011). Diabetes and CAD were found in 27% and 29% of 
cases respectively upon admission to RUH.  Canadian statistics on cardiac artery disease 
compared similarly to that of Saskatchewan stroke population studied (CSN, 2011).  The 
Saskatchewan sample had a somewhat higher history of diabetes with 29% compared to the 
Canadian results of 24%.  This difference may be due to sample size, or for reasons related to a 
higher instance of diabetes in Saskatchewan (PHAC, 2012).  Provincial statistics illustrate the 
prevalence of diabetes in Saskatchewan is increasing.  It has been shown that diabetes incidence 
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has increased from an 8% of the population in 2005 to 11% in 2010 (PHAC, 2012).  The most 
recent national information (2008/2009) shows that 6.8% of the population is affected by 
diabetes and Saskatchewan is one of the four provinces showing the greatest increase over the 
previous 11 years (PHAC, 2012).  The Public Health Agency of Canada also reports “the socio- 
cultural, biological, environmental and lifestyle changes seen in the First Nations, Inuit and 
Métis populations in the last half century have contributed significantly to increased rates of 
diabetes and its complications” (chapter 6, para. 4).  With the sixth highest Aboriginal population 
in the country, the difference could also be contributed to the high rates of diabetes among 
Aboriginal populations in Saskatchewan. Due to the inability to collect ethnic information in 
hospital records, no conclusions can be made regarding the possibility of higher risk of stroke by 
ethnic origin. 
Atrial fibrillation alone accounts for up to 15% of the strokes seen in Canada (PHAC, 2009) 
Analyzing the use of medication for atrial fibrillation is difficult since cases with no prior history 
of stroke or TIA may be managed with heart rate control medications (Wann et al. 2011).  The 
use of anticoagulation for atrial fibrillation is indicated following a stroke or TIA with the 
exception of those at risk of bleeding complications (Lindsay et al., 2008).  Of the166 cases of 
ischemic stroke identified, 21.1% had a diagnosis of atrial fibrillation however, only 40.0% of 
the cases demonstrated the use of an anticoagulant.  In addition, 37.9% of cases indicated a 
previous history of stroke or TIA which would indicate the need for medications used in 
secondary prevention; however 38.1% of these cases were not taking Coumadin or Clopidogrel 
where the risk of bleeding was too high to use Coumadin. There were 48.2% of cases where the 
patient was taking ASA; a medication that can be used in primary or secondary prevention 
making it not possible to accurately calculate the number of cases adequately treated with the 
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appropriate medication.  It is unclear from this study information whether the use of these 
medications was for primary or secondary prevention.  Future research should explore the use of 
medications for stroke treatment and prevention on the basis of first or second stroke or TIA to 
clarify issues around the intended use of medications. 
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5.1.2.5  Dyslipidemia 
 
Dyslipidemia has long been recognized as a significant risk factor for stroke for more than a 
decade (Hachinski et al. 1996; Amarenco et al. 2009).  Nearly half of the study cases had a 
documented diagnosis of dyslipidemia and 69% of the stroke cases with the diagnosis of 
dyslipidemia were not currently taking a lipid lowering medication.   Initial studies such as the 
MORGAM study did not find an association between cholesterol levels and risk of stroke 
however, several large trials such as the SPARCL trial and the Framinham Heart Study have 
concluded that the risk of a cardiovascular event is lowered by 30% with the use of lipid 
lowering medications (Amarenco et al., 2009; D’Agostino et al, 1994). 
5.1.2.6  Obesity 
 
Obesity has been linked with cardiac artery disease, diabetes, and hypertension and has been 
identified as one of the five risk factors responsible for more than 80% of the global risk of all 
stroke (Strazullo et al. 2010; O’Donnell et al. 2010). It was difficult to analyze obesity in the 
Saskatchewan stroke case population because case documentation of obesity was absent in 
70.7% of the stroke cases admitted to RUH.  However, non-obesity and morbid obesity were 
noted in 22.8% and 6.5% of the cases respectively. 
Recent studies have examined obesity and stroke and found that obesity as measured by body 
mass index, is linked to stroke (Go et al., 2010; James et al., 2004; Lakka and Laaksonen, 2007). 
Weight as part of BMI may not be the best indicator to use in assessing stroke risk.  More 
specifically the SPARCL trial examined the categorization of weight in over 4700 cases of stroke 
in which the average weight fell within the overweight category.  The study found that with 
accurate recording of weight, a higher number of cases in the overweight or obese ranges 
become apparent (Amarenco et al. 2009).  Recently, the INTERSTROKE study has shown that 
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even in cases where obesity was not indicated, the measurement of abdominal girth was a better 
indicator of stroke risk (O’Donnell et al. 2010).  BMI or waist measurement not routinely 
recorded in hospital charts that were reviewed.  Although obesity is becoming more prevalent in 
our society this is not reflected in the documentation found in the hospital records (James et al. 
2004; PHAC, 2012). The under reporting of obesity is an issue in terms of stroke prevention and 
perhaps is an indicator of inadequate record keeping for this particular risk factor. Additionally, 
the failure of to record and recognize obesity as a major risk factor of stroke does not facilitate a 
plan for current or future weight loss programs for individuals at higher risk for stroke.  Bardia et 
al., (2007) examined the documentation of obesity in medical records and concluded that obesity 
is not routinely documented by physicians.  Obesity is a major public health concern and without 
documentation, formal weight loss plans will not be initiated to help control this major health 
issue (Bardia et al. 2007).  Waist circumference would be relatively easy to measure during an 
acute stroke event and gives a better indication of stroke risk. 
5.2 Question Two 
 
What types of treatments are provided to stroke cases at the Royal University Hospital and 
how do they compare to national guidelines for timeliness and comprehensiveness during 
the acute and hospital phases of care? 
 
5.2.1  Description of acute management 
 
5.2.1.1  Door to needle times 
 
The time to treatment is an essential aspect of stroke patient care. The healthcare system assumes 
responsibility for swift and efficient care when stroke cases reach the hospital door. The three 
factors examined in this study regarding door to needle times were time to phlebotomy, ECG and 
CT scan. Critical to any hospital’s acute stroke protocol is the rapid recognition and action 
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required to have a CT scan done, to rule out the possibility of a hemorrhagic stroke, blood work 
done to ensure that PTT and INR values lie within the criteria for the use of thrombolytic therapy 
(tPA). As well, an ECG is also required for cardiac rhythm assessment.  Treatments for 
hemorrhagic strokes are dealt with through medical or surgical intervention depending on the 
severity of the bleed, but also require rapid assessment including phlebotomy and ECG. 
The expectation for phlebotomy and ECG times is that they are done as soon as possible 
following registration (Lindsay et al. 2010).  Excluding those who came with results for these 
tests already completed, the times recorded in the current study varied from immediate for both 
tests to nearly 1.5 hours for phlebotomy and 2 hours for ECG. 
The Canadian Audit found that only eight percent of cases being admitted with ischemic stroke 
across the country received treatment with tPA CSN, 2011). The CSN also noted that in the 
province of Saskatchewan, ten percent of stroke cases admitted with ischemic stroke are treated 
with tPA (CSN, 2011).  The CSN results for RUH also showed a ten percent treatment with tPA . 
Although in the current study 33% of cases arrived within the potential treatment window.  This 
would indicate that there were 23% of cases in the treatment window time did not meet the 
inclusion criteria for treatment with tPA.  This research did not look specifically at the reasons 
for thrombolytic therapy exclusion however; this information would be valuable for strategies to 
increase therapy rates. 
The Canadian Best Practice Recommendations for Stroke state thrombolytic therapy should be 
started in less than one hour for the cases arriving within 4 ½ hours from onset of symptoms. 
There were 23 cases recorded as having been given tPA admitted to hospital in this research 
however, three of these cases had received therapy at another institution and subsequently 
transferred to RUH.  Of the 20 cases receiving tPA at RUH, the minimum door to needle time 
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was 29 minutes and the maximum was 214 min. with a mean time of 70 min.  The maximum and 
mean times are in excess of 1 hour indicating that there is room for improvement in this area. 
The Canadian Stroke Audit completed by CSN and HSFC (2011) found that “in two-thirds of the 
cases where tPA was administered, the door-to-needle (arrival to administration) time was 
greater than one hour, with a median time of 72 minutes” p.21.  It appears that the Royal 
University Hospital exceeds the national average for the number of cases treated with tPA and 
meets but does not exceed the national average in the time taken for the treatment to be initiated. 
Common impediment to treatment can include delays in lab results, lack of available history or 
equipment failures.  It is also possible that more time was taken with cases arriving with ample 
treatment time however; this information was not included in the study. 
5.2.1.2  In hospital care 
 
The Canadian Best Practice Recommendations for Stroke Care states that  “when a patient with a 
stroke is admitted to hospital it is important that the care he/she receives is focused on recovering 
from the stroke, preventing complications, and preventing a recurrent stroke” (CSN and HSFC, 
2011).  The results of this study revealed that every case in the study received a CT scan, and 
almost half of the cases studied received a second scan while in hospital.  Tests to discover the 
etiology of the stroke included a carotid ultrasound, echocardiogram, and Holter monitoring. 
These tests were completed on the majority of stroke cases while in the RUH.MRI’s were 
completed on only 21% of the cases possibly because the CT scan gave the same basic 
information required to manage most strokes and the additional knowledge gained by an MRI 
would only be required for harder to diagnose cases.  The reasons for some cases receiving 
certain tests and not others can only be speculated on with the information gained from the study 
and would require a more in depth study of the individual cases for an explanation. 
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5.2.1.3  Discharge destination 
 
The impact of stroke is largely determined by how completely cases can resume their former 
lifestyle (PHAC, 1993; Luengo-Fernandez et al., 2009). The only indication of stroke outcome 
was the case destination following discharge.  Ten percent of patients in this study did not 
survive the stroke event. The stroke resulted in a loss of independence for the majority of cases. 
Of the 197 cases in the study, 80.2% were living independently at the time of their stroke 
however; approximately 55% were unable to return directly to their own homes.  Approximately 
16% were transferred to a rehabilitation program with the possibility of later full recovery.  A 
percentage of those who qualified for rehabilitation were expected to fully regain their 
independence, and the remainder to live with ongoing deficits.  A total of 54 cases who were 
previously contributing members of society are no longer able to live independently.  This 
signifies an untold impact on the families, friends and communities involved as well as a 
considerable financial impact reported as being over 3.6 billion dollars in health care costs 
(PHAC, 1997; Luengo-Fernandez et al., 2009) The consequences of lost years of productivity in 
addition to the costs associated with acute care, rehabilitation, and long term care represent the 
burden of stroke.  Much of this burden is incalculable in dollars and cents however; this makes it 
no less significant in a comprehensive representation of stroke. 
5.3 Study Strengths 
 
The sample of cases was randomly selected for the study represented slightly less than half of the 
total admissions for stroke and TIA in the designated time period of one year.  From this sample, 
information was gained on the nature of stroke management for rural Saskatchewan residents 
that has not been previously examined in the literature.  The study provides an examination of 
stroke care from admission to discharge. 
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5.4 Study Limitations 
 
The study was a retrospective examination of health care for stroke cases from hospital records 
and reflects the problems with routinely collected dated when it is used to examine specific care 
needs related to a diagnosis.  No comparisons were made to the total number of strokes and TIAs 
admitted to Royal University Hospital for the period of April 1, 2009 to March 31, 2010, 
therefore results of this study may not be representative of the population of Saskatchewan. 
Limitations to the research also include the inability to identify the ethnic background of cases. 
The population of Saskatchewan includes a strong representation of Aboriginal people.  A large 
number of these people live in the northern regions categorized in the study as rural and remote 
rural.  Without the ability to collect ethnic information, no support can be given to ethnically 
sensitive programs or strategies. 
Strokes and TIA can occur at any age but only cases 55 years and over were included in this 
study and the results are therefore not representative of all strokes occurring during the study 
period.  In addition, hospital admissions include only a portion of all stroke and TIA cases 
occurring in the health regions included in the study and the results presented may under 
represent the number of strokes and their impact. 
The research gathered retrospective data obtained from hospital charts and was therefore limited 
to what was recorded by the hospital personnel.  As a result, a true measure of obesity as a risk 
factor could not be made with the information available in the hospital chart.  In addition, the 
barriers to medication adherence, delays in seeking treatment and delays in reaching treatment 
could not be collected. 
Functional scales indicating physical and mental ability are not routinely used for stroke and TIA 
 
at the Royal University Hospital that would have provided more detailed information on 
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disability at discharge.  Finally, the sample was taken from one fiscal year and represents only a 
fraction of the stroke cases being admitted to RUH on an ongoing basis and hospital care could 
differ somewhat from year to year based on hospital policies and current standards of practice for 
that time period. 
5.5 Implications for Practice 
 
Nurses are in a position to play a pivotal role in stroke prevention through the detection and 
control of hypertension, control of dyslipidemia, and the management of diabetes and cardiac 
artery disease.   The promotion of exercise, healthy diets, and cessation of cigarette smoking are 
vital at all ages but are of particularly important in aging adults.  The study results imply that 
men tend to have multiple risk factors earlier than women increasing their risk and making them 
a target for early intervention programs. 
Targeted primary prevention strategies to manage multiple risk factors in younger males need to 
be addressed through both public awareness campaigns and family physician education to 
promote healthy choices for their patients as they carry out medical management.  Women in the 
study showed a tendency to develop more risk factors as they age and although the same 
prevention strategies would be beneficial, increased age also brings with it the possibility of age 
related barriers to risk management for instance decreased mobility, balance, etc.  Education and 
medical management of these risk factors should occur as early as possible with a focus on the 
dangers posed by multiple risk factors especially in middle aged men and women as they move 
toward older age. 
Controlling risk factors often includes the use of medications that need to be taken as prescribed 
by their physician to be effective.  When non-adherence concerns are recognized, the underlying 
issues need to be identified and steps taken for positive resolution.  Nurses in key locations such 
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as community health and wellness centres may have an opportunity to facilitate constructive 
solutions and prevent the elevated stroke risk associated with non-adherence. The reasons for 
medication non-compliance are complex and specific to each case.  Healthcare professionals 
need to be aware of barriers to sustained use of statins and provide education and provide support 
directed at the reduction of cholesterol levels to reduce risk.  Additional challenges faced by 
healthcare professionals include education, and encouragement to achieve and sustain behavioral 
changes to reduce lipid levels. 
Stroke and TIA treated in hospital have a record of the treatment received that can be used to 
measure performance through standards provided in national recommendations (CSN, 2010). 
Formal tracking of adherence to best practice recommendations through performance measures 
is not a current hospital practice and the adoption of this practice would have the potential to 
improve stroke care.  The expectation of improved stroke care and treatment should be 
measurable in the outcomes following discharge (CSN, 2010).  These outcomes are not currently 
tracked past discharge from hospital care.  More comprehensive surveillance of stroke outcomes 
would provide feedback for current in hospital practice and make available a greater 
understanding of the impact of stroke. 
The study showed that two thirds of the cases admitted to Royal University Hospital arrived too 
late for thrombolytic therapy.  Awareness of the signs and symptoms of stroke and the urgency 
required in seeking medical attention needs to be promoted in every healthcare setting to reduce 
delays to treatment. 
In this study, rural and remotely rural individuals who did not have local access to a CT scanner 
had longer transportation time which would have put them at risk of being ineligible for 
thrombolytic therapy.  As well, of the 91 previously independent cases that came from urban 
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centres outside of Saskatoon, rural, and remote rural settings, just less than half were transferred 
to their home hospital following their acute treatment unable to return to their homes as they 
were not a candidate for rehabilitation at the time of their discharge. 
The Canada Health Act guarantees portability, universality, comprehensiveness, and accessibility 
to health care for all Canadians (Government of Canada Department of Justice, 1985). 
Obviously in this study these criteria were not being met for acute stroke cases.  Access to CT 
scanners and a neurologist by telehealth could improve the quality of life of ischemic stroke 
cases (the majority of stroke cases) post discharge if treatment were readily accessible. 
5.6 Conclusion 
 
The research describes the population affected by stroke and admitted to Royal University 
Hospital for treatment in 2009-2010.  In addition to the description, four performance measures 
were examined to evaluate whether Royal University Hospital met selected Canadian 
recommendations for stroke care. 
In many of the general categories being described such as age, gender and type of stroke, the 
results of the study closely resemble those of the national audit conducted by the CSN in 
conjunction with the HSFC.  The similarity of results provides a sense of confidence in using 
national statistics for future studies and programs relying on this information to be representative 
of the Saskatchewan population.  The study also identified areas where there is need for 
improvement such as the arrival times for treatment recognizing that two thirds of the cases did 
not arrive in time to be considered for thrombolytic therapy.  The use of national performance 
measures provides a tool for evaluation of stroke care practices is recommended for the Royal 
University Hospital.  The evaluation is an important step towards excellence in stroke care for 
this regional stroke centre. 
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All regions of the province do not have equal accessibility to stroke care with only a third of the 
rural cases and none of the remote rural cases arriving to Royal University Hospital in time for 
acute ischemic stroke treatment options.  Solutions are needed to address the barriers faced by 
residents of these regions to access treatment rapidly. While solutions are developed to reduce 
delays in accessing to treatment, primary prevention of stroke through medical management and 
effective programs to promote lifestyle changes are essential. 
The number of risk factors experienced in the cases being admitted showed that men tend to have 
a greater number of risk factors at an earlier age whereas women tend to accumulate risk with 
age.  Additional research in this area to discover the reasons for this difference could provide 
valuable educational tools to enable the reduction of modifiable risk factors for both men and 
women.  In many of the cases, the case history showed multiple known risk factors for stroke 
although in many cases medications known to be used in the treatment of these factors were not 
currently prescribed.  Future research into the possible causes of this finding could be used to re- 
frame approaches to prevention strategies and further reduce the risk of stroke. 
The care of stroke cases during their hospitalization at Royal University Hospital met the selected 
performance standards from the Canadian Best Practice Recommendation for Stroke (2010).  
Despite this fact, nearly half of the cases who had been living independent lives prior to their 
stroke required complete or partial care at hospital discharge.  The lost years of productivity as 
well as the ongoing costs associated with continuing care have a substantial impact on 
families, communities and the province.  Again, the uptake of performance measure as a hospital 
function has the potential to reduce this impact, and could be utilized to identify areas for the 
improvement of outcomes and promote the highest standard of care.This study provides a 
description; including relevant health history, for 197 stroke cases admitted to Royal University 
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Hospital, the care they received while in hospital and their ability to live independent lives at the 
time of their discharge.  Several areas have been identified where additional investigation could 
provide information to inform health professionals in their efforts to improve stroke prevention 
and care in Saskatchewan. 
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APPENDIX A: Data Collection Tool 
 
 
Saskatchewan Stroke Enquiry 
 
Data Collection Tool 
 
1. SUBJECT #   
 
2. Gender:  □ male □ female 
 
3. Age  yrs. 
 
4. Community:□ Saskatoon □ Urban  □ Rural  □ Remote rural 
 
 
Bio # 
 
5. Date of registration in Emergency dept. (dd.mm.yy)      .    .   
 
6. ETHNICITY (self identified):□ Aboriginal – Status   □ Aboriginal – non-status 
 
□ Afro-Caribbean   □ Caucasian   □ Inuit   □ Métis   □ Middle Eastern   □ unknown 
 
□ Oriental □ Other – specify:   
 
7.  Did the case live in their own home or that of a relative but were independent prior to the 
event?  □ no  □ yes   □ unknown 
RISK FACTORS 
 
 
DID THE CASE HAVE: 
 
8. Hypertension □ no □ yes □ unknown 
 
9. Diabetes □ no □ yes □ unknown 
 
10. Dyslipidemia □ no □ yes □ unknown 
 
11. Obesity □ no □ yes □ unknown 
 
12. Alcohol abuse (>5 drinks/wk) □ no □ yes □ unknown 
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13. Smoking □ no □ yes □ unknown □ stopped □ never smoked 
 
14. Family history of stroke □ no □ yes □ unknown 
 
15. Previous ischemic stroke □ no □ yes □ unknown 
 
16. Previous TIA □ no □ yes □ unknown 
 
17. Previous intracranial hemorrhage □ no □ yes □ unknown 
 
CARDIAC RISK FACTORS 
 
 
18. Previous myocardial infarction □ no □ yes □ unknown 
 
19. Cardiac artery disease □ no □ yes □ unknown 
 
20. Previous cardiac surgery □ no □ yes □ unknown 
 
21. Previous atrial fibrillation □ no □ yes □ unknown 
 
22. Congestive heart failure □ no □ yes □ unknown 
 
PREVIOUS MEDICATIONS TO TREAT 
 
23.Was the case on asa prior to event? □ no □ yes □ unknown 
 
24. Was the case on clopidogrel prior to event? □ no □ yes □ unknown 
 
25. Was the case on warfarin prior to event? □ no □ yes □ unknown 
 
26. Hypertension □ no □ yes □ unknown 
 
27. Diabetes non insulin dependent □ no □ yes □ unknown 
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28. Diabetes insulin dependent □ no □ yes □ unknown 
 
29. Hypercholesterolemia □ no □ yes □ unknown 
 
30.  Arrival at hospital was by: □ ambulance □ private transport  □ air ambulance 
 
31.  Elapsed time from onset of symptoms (as determined by physician) to the time of 
registration if less than 4.5 hours (on the registration sheet).(In minutes) 
32.  Elapsed time from onset of symptoms (as determined by the physician) to the time of 
registration if greater than 4.5 hours: 
□ 4.5-6 hrs □ 6-12hrs □ 12-24hrs □ >24hrs 
 
33. Was asa given prior to arrival at hospital? □ no □ yes 
 
34. Was asa or clopidogrel (plavix) given in the emergency department? 
 
□ no □ yes 
 
35. Time or registration   (24hr) 
 
36. Time of CT scan 
 
  (24hr) if less than 24hours 
 
37.  Did the case receive tPA? □ no □ yes 
 
38.  Time of tPA administration)?   (24hr) 
 
38. Date of admission to hospital (dd.mm.yy) __.    .   
 
TESTS 
 
 
40. Time of first phlebotomy   (24hr) 
 
41. Did lab requisition include electrolytes, cbc, INR, & glucose. □ no □ yes 
 
42. Time of electrocardiogram   (24hr) 
 
43. second CT scan □ no □ yes 
 
44. CT angiogram □ no □ yes 
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45. Carotid Ultrasound □ no □ yes 
 
46. Echocardiogram □ no □ yes 
 
47. MRI □ no □ yes 
 
48. Holter monitor □ no □ yes 
 
PROCEDURES 
 
 
49. Was carotid stenosis treated through endarterectomy or stenting while in hospital? 
 
□ no □ yes 
 
 
 
 
 
50. Ischemic □ no □ yes 
TYPE OF STROKE 
 
51. Intracerebral hemorrhage □ no □ yes 
 
52. Subarachnoid hemorrhage □ no □ yes 
 
HOSPITALIZATION 
 
 
53. Number of days in hospital:     
 
54. Discharge destination: □ home □ rehabilitation □ long term care 
 
□ home hospital (transfer) 
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APPENDIX B: Code Book 
 
DESCRIPTION OF 
VARIABLE 
 
VARIABLE 
NAME 
 
 
CODING  INSTRUCTIONS 
IDENTIFICATION 
NUMBER 
 
 
id 
 
 
individual assigned number 
   
GENDER sex 1= female 
  2= male 
   
AGE age in years 
   
ETHNICITY ethnic 1= Caucasian 
  2= Aboriginal - First Nations 
  3= Aboriginal - not First Nations 
  4= Métis 
  5= Inuit 
  6= Oriental 
  7= Black 
  8= Middle Eastern 
   
COMMUNITY OF 
RESIDENCE 
 
 
comm 
 
 
1= Saskatoon 
  2= urban 
  3= rural 
  4= remote rural 
5= reservation 
   
PREVIOUSLY 
INDEPENDENT 
 
 
indep 
 
 
1= yes 
  2= no 
   
TIME FROM ONSET 
TO REGISTRATION 
 
 
time 
 
 
1=  < 1hour 
  2=  1 - 3 hours 
  3=  3 - 4 1/2 hours 
  4=  4 1/2 - 6 hours 
  5=  6 - 12 hours 
  6=  12 - 24 hours 
  7=  > 24 hours 
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DELAY BY 
INDIVIDUAL/FAMILY 
IN SEEKING 
ASSISTANCE 
 
 
 
 
delay 
 
 
 
 
0=no  1= yes  2=unknown 
OTHER  DELAYS 
PRIOR TO ARRIVAL 
 
 
other 
 
 
0=no  1= yes  2=unknown 
   
ARRIVAL TO 
HOSPITAL BY 
AMBULANCE 
 
 
 
transp 
 
 
0=ambulance 1=private 
transportation 
  2=air  ambulance 
   
STOPPED AT LOCAL 
HOSPITAL (referal by 
FP) 
 
 
 
stop 
 
 
 
0=no  1= yes  2=unknown 
   
RECEIVED tPA tPA 0=no  1= yes 
DOOR TO NEEDLE 
TIME 
 
 
min 
number of minutes from registration 
time to time of tPA start 
   
RISK FACTORS   
HYPERTENSION htn 0=no  1= yes  2=unknown 
   
DIABETES ddm 0=no  1= yes  2=unknown 
   
DYSLIPIDEMIA lipid 0=no  1= yes 2=unknown 
   
OBESITY obese 0=no  1= yes 2=unknown 
   
ALCOHOL ABUSE etoh 0=no  1= yes  2=unknown 
   
SMOKING smoke 0=no  1= yes  2=unknown 
  3= stopped  4=never  smoked 
PAST CAROTIC 
ENDARTERECTOMY 
 
 
endart 
 
 
0=no  1= yes  2=unknown 
FAMILY HISTORY OF 
STROKE OR 
MYOCARDIAL 
INFARCTION 
 
 
 
 
fhx 
 
 
 
 
0=no  1= yes  2=unknown 
PREVIOUS STROKE ps 0=no  1= yes  2=unknown 
PREVIOUS 
INTRACRANIAL 
HEMORRHAGE 
 
 
 
ich 
 
 
 
0=no  1= yes  2=unknown 
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PREVIOUS TIA ptia 0=no  1= yes  2=unknown 
PREVIOUS 
SUBARACHNOID 
HEMORRHAGE 
 
 
 
sah 
 
 
 
0=no  1= yes  2=unknown 
   
CARDIAC RISK 
FACTORS 
  
PREVIOUS 
MYOCARDIAL 
INFARCTION 
 
 
 
mi 
 
 
 
0=no  1= yes  2=unknown 
   
CARDIAC ARTERY 
DISEASE 
 
 
cad 
 
 
0=no  1= yes  2=unknown 
   
PREVIOUS 
CARDIAC SURGERY 
 
 
heartsx 
 
 
0=no  1= yes 2=unknown 
   
CONGESTIVE 
HEART  FAILURE 
 
 
chf 
 
 
0=no  1= yes  2=unknown 
   
ATRIAL 
FIBRILLATION 
 
 
afib 
 
 
0=no  1= yes  2=unknown 
   
   
INR inr actual number 
   
CREATININE cr 0= within  normal range 
  1= above normal range, but not 2X 
upper normal 
  2= >2X upper normal  range 
 
 
 
NIH STROKE SCALE 
SCORE 
 
 
nih 
 
 
actual score 
SYMPTOMS   
UNILATERAL 
WEAKNESS 
 
 
weak 
 
 
0=no  1= yes  2=unknown 
HEADACHE ha 0=no  1= yes  2=unknown 
SPEECH 
DIFFICULTY 
 
 
speech 
 
 
0=no  1= yes  2=unknown 
BALANCE bal 0=no  1= yes  2=unknown 
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DIFFICULTY   
VISUAL CHANGE see 0=no  1= yes  2=unknown 
NAUSEA nausea 0=no  1= yes  2=unknown 
FACIAL  DROOP droop 0=no  1= yes  2=unknown 
 
 
 
UNILATERAL 
NUMBNESS  AND/OR 
TINGLING 
 
 
 
numb 
 
 
 
0=no  1= yes  2=unknown 
   
PREVIOUS 
MEDICATIONS 
  
ACETYLSALYSILIC 
ACID (ASA) 
 
 
asa 
 
 
0=no  1= yes  2=unknown 
   
CLOPIDOGREL 
(PLAVIX) 
 
 
plavix 
 
 
0=no  1= yes  2=unknown 
   
STATIN 
(ATORVASTATIN, 
SIMVASTATIN, ETC.) 
 
 
 
statin 
 
 
 
0=no  1= yes 2=unknown 
   
ORAL 
HYPOGLYCEMIC 
 
 
niddm 
 
 
0=no  1= yes  2=unknown 
   
INSULIN iddm 0=no  1= yes  2=unknown 
   
HYPERTENSION 
TREATMENT 
 
 
hyper 
 
 
0=no  1= yes  2=unknown 
   
WARFARIN 
(COUMADIN) 
 
 
warfarin 
 
 
0=no  1= yes  2=unknown 
   
   
SOURCE OF STROKE source 1= cardioembolic 
  2= atherothrombotic 
  3= other 
  4= unknown 
   
DAYS OF 
HOSPITALIZATION 
 
 
days 
 
 
number of days 
   
TESTS   
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TRANSTHORASIC 
ECHOCARDIOGRAM 
 
 
echo 
 
 
0=no  1= yes  2=unknown 
   
CAROTID 
ULTRASOUND 
 
 
ultra 
 
 
0=no  1= yes  2=unknown 
CT ANGIOGRAM cta 0=no  1= yes  2=unknown 
   
 
 
 
HOLTER  MONITOR holter 0=no  1= yes  2=unknown 
   
MRI mri 0=no  1= yes  2=unknown 
   
EEG eeg 0=no  1= yes  2=unknown 
   
EMG emg 0=no  1= yes  2=unknown 
   
NERVE 
CONDUCTION 
STUDIES 
 
 
 
ncs 
 
 
 
0=no  1= yes  2=unknown 
   
THROMBOPHILIA 
SCREEN 
 
 
lab 
 
 
0=no  1= yes  2=unknown 
   
   
DISCHARGE 
DIAGNOSIS 
 
 
Dx 
 
 
0= stroke 
  1= TIA 
  2= other 
   
DISCHARGE 
DESTINATION 
 
 
dest 
 
 
0= home (independent) 
  1= home (with family support) 
  2= home hospital 
  3= rehabilitation 
  4= long term care facility 
  5= deceased 
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APPENDIX C: Defining Communities based on Saskatchewan Health Regions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMMUNITY: City of Saskatoon 
Urban but not including Saskatoon (pop. >5000) 
Rural (Sunrise, Saskatoon, Heartland, Prairie North, Parkland, and Kelsey Trail Health 
Regions not in an urban centre) 
Remote Rural (Mamawetin Churchill River, Keewatin Yatthe, and Athabasca Health 
Regions) 
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APPENDIX D 
 
 
 
(I60) Subarachnoid hemorrhage 
INCLUDED ICD CODES 
o (I60.0) Subarachnoid haemorrhage from carotid siphon and bifurcation 
o (I60.1) Subarachnoid haemorrhage from middle cerebral artery 
o (I60.2) Subarachnoid haemorrhage from anterior communicating artery 
o (I60.3) Subarachnoid haemorrhage from posterior communicating artery 
o (I60.4) Subarachnoid haemorrhage from basilar artery 
o (I60.5) Subarachnoid haemorrhage from vertebral artery 
o (I60.6) Subarachnoid haemorrhage from other intracranial arteries 
o (I60.7) Subarachnoid haemorrhage from intracranial artery, unspecified 
(I61) Intracerebral haemorrhage 
o (I61.0) Intracerebral haemorrhage in hemisphere, subcortical 
o (I61.1) Intracerebral haemorrhage in hemisphere, cortical 
o (I61.2) Intracerebral haemorrhage in hemisphere, unspecified 
o (I61.3) Intracerebral haemorrhage in brain stem 
o (I61.4) Intracerebral haemorrhage in cerebellum 
o (I61.5) Intracerebral haemorrhage, intraventricular 
o (I61.6) Intracerebral haemorrhage, multiple localized 
(I62) Other nontraumatic intracranial haemorrhage 
o (I62.0) Subdural haemorrhage (acute)(nontraumatic) 
o (I62.1) Nontraumatic extradural haemorrhage 
 Nontraumatic epidural haemorrhage 
(I63) Cerebral infarction 
o (I63.0) Cerebral infarction due to thrombosis of precerebral arteries 
o (I63.1) Cerebral infarction due to embolism of precerebral arteries 
o (I63.2) Cerebral infarction due to unspecified occlusion or stenosis of precerebral 
arteries 
o (I63.3) Cerebral infarction due to thrombosis of cerebral arteries 
o (I63.4) Cerebral infarction due to embolism of cerebral arteries 
o (I63.5) Cerebral infarction due to unspecified occlusion or stenosis of cerebral 
arteries 
(I64) Stroke, not specified as hemorrhage or infarction 
(I67.6) Nonpyogenic thrombosis of intracranial venous system 
 
Cerebrovascular 
(G45) Transient cerebral ischaemic attacks and related syndromes 
o (G45.0) Vertebrobasilar artery syndrome 
o (G45.1) Carotid artery syndrome (hemispheric) 
o (G45.2) Multiple and bilateral precerebral artery syndromes 
o (G45.3) Amaurosis fugax 
o (G45.8) Other transient cerebral ischaemic attacks and related syndromes 
o (G45.9) Transient cerebral ischaemic attack, unspecified 
(H34) Retinal vascular occlusions 
o (H34.0) Transient retinal artery occlusion 
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o (H34.1) Central retinal artery occlusion 
o (H34.2) Other retinal artery occlusions 
 Hollenhorst's plaque 
o (H34.8) Other retinal vascular occlusions 
 Central retinal vein occlusion 
o (H34.9) Retinal vascular occlusion, unspecified 
 
EXCLUDED ICD CODES 
 
o (G45.4) Transient global amnesia 
o (G160.8) Malignant neoplasm of other accessory sinuses 
o (163.6) Cerebral infarction due to cerebral venous thrombosis, nonpyogenic 
o (163.8) Malignant neoplasm of other specified sites of pleura 
